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About the EMCDDA
The European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) is the central source and 
confirmed authority on drug-related issues in Europe. 
For over 20 years, it has been collecting, analysing and 
disseminating scientifically sound information on drugs 
and drug addiction and their consequences, providing 
its audiences with an evidence-based picture of the 
drug phenomenon at European level. 
The EMCDDA’s publications are a prime source of 
information for a wide range of audiences including: 
policymakers and their advisors; professionals and 
researchers working in the drugs field; and, more 
broadly, the media and general public. Based in Lisbon, 
the EMCDDA is one of the decentralised agencies of 
the European Union.
About this series
EMCDDA Insights are topic-based reports that bring 
together current research and study findings on a 
particular issue in the drugs field.  This report considers 
how therapeutic communities have developed in 
Europe since their creation in the 1960s and their 
effectiveness as a treatment option for drug users.
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5I Foreword
Therapeutic communities first developed in the 1960s, and have continuing relevance in 
the world of drug treatment today. Fifty years ago, drug use and related phenomena were 
seen as an increasing problem in Europe, while the means to meet this challenge were very 
limited. Many drug users, especially heroin addicts, were in need of treatment, and existing 
health and social care services were ill-equipped for the task. 
At this point, therapeutic communities appeared. Often without public funding, based on 
self-help and a strong feeling of responsibility towards this target group, they quickly 
played a very important role offering help and support to drug addicts. Some shortcomings 
of this approach soon became apparent, including a lack of professionalism, problems of 
scaling up provision, and charismatic leadership that was sometimes lacking control and 
balance. 
Now, 50 years later, the situation of drug use and drug treatment has changed 
considerably. A variety of different treatment programmes and interventions is available, 
their effects proven by research findings. Even with these positive developments, for a 
number of drug users stabilisation is the most positive result that can be achieved. In 
addition, with new generations of drug users, the choice of substances has changed. The 
ongoing discussion about which interventions should be used and developed further has 
intensified recently in a number of countries, taking a more critical look at the status quo of 
drug treatment. 
Given this situation, the EMCDDA found it very relevant and timely to investigate the 
experience gained with therapeutic communities as an approach to treatment. In addition 
to looking back to see how these concepts developed in Europe and the role they play in 
EU Member States today, we wanted to provide policymakers, therapists and experts in 
the field with an overview of the evidence available for this intervention to allow a critical 
view of the state of its development. 
In this publication we examine the development of therapeutic communities and their 
availability in Europe, with specific reference to seven countries. We provide an overview of 
research into the effectiveness of therapeutic communities as a treatment option (some 
conclusions are positive, others less so) and their impact on wider society, for example in 
terms of crime reduction. A treatment option can only be measured against recognised 
standards, and we also look at the guidelines which govern them and consider their 
implications for management and training needs.
The result of intensive collaboration between authors, peer reviewers and the internal 
EMCDDA team, this publication will provide readers with new insights, ideas and food for 
thought in the areas of quality of care and service provision. 
Wolfgang Götz 
Director, EMCDDA
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9I Executive summary
I What is a therapeutic community?
The term ‘therapeutic community’ (TC) has been linked to a range of treatment traditions 
and approaches that all share the idea of using the relationships and activities of a 
purposefully designed social environment or residential treatment setting to promote 
social and psychological change. TCs offer a drug-free environment in which people with 
addictive (and other) problems live together in an organised and structured way in order to 
promote change and make it possible for them to lead a drug-free life in the outside 
society. The key distinctive characteristic of the TC is the use of the community itself as a 
fundamental change agent (‘community as a method’). There are a number of defining 
features of the ‘community as method’ approach, including the use of a range of structured 
activities in which both staff members and residents are expected to participate and the 
use of peers as role models who set a positive example and demonstrate how to live 
according to the TC’s philosophy and value system.
I History of therapeutic communities
From a historical perspective, the TC for the treatment of addictions was one of the first 
treatment approaches developed to respond to the emerging heroin problem in many 
European countries during the 1960s. While European TCs were initially inspired by the 
North American concept (or hierarchical) TCs, they have developed their own identity: the 
behaviourist approach of US TCs has been complemented by European educational 
theories, psychoanalytical thinking, social learning, the involvement of trained 
professionals (instead of recovered ex-addicts serving as staff members) and a more 
family-oriented approach. Despite a number of common elements, however, substantial 
heterogeneity can be observed between European TC programmes.
Over the course of the 1990s, and largely in response to a changing environment with 
growing interest in harm reduction programmes and new groups of clients in need of drug 
treatment, TCs in many European countries gradually evolved from long-term, generic 
treatment programmes to a shorter-term, modified approach. Often this was tailored to 
respond to the needs of specific groups of drug users, such as drug-using women with 
children, imprisoned drug users and individuals suffering from psychiatric disorders in 
addition to their drug problems.
I Therapeutic community availability and practice
Although TC programmes for the treatment of addictions exist in most European countries, 
the use of this approach is not equally distributed. Overall, around 1 200 facilities using 
TC-type interventions were identified across Europe — with Italy contributing two-thirds of 
these. While the number of programmes applying the TC approach was low (around five) in 
many European countries, the TC appeared to be a prevalent treatment modality in most 
south and some east European countries. Typically, the capacity of facilities offering a TC 
programme in Europe was between 15 and 25 residents. In most countries the planned 
length of treatment in TCs ranged between 6 and 12 months.
In recent years, a general European trend towards the limitation of funding for intensive 
long-term treatment has resulted in the closure of a number of TC programmes and also in 
a reduction in programme length and the number of client places provided. France is the 
only country where the TC approach to the treatment of addictions has been re-
Therapeutic communities for treating addictions in Europe
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established in recent years. In addition, a number of TC programmes have been modified 
to offer treatment to specific groups, such as drug-using women with children (e.g. 
Belgium) and drug addicts with concomitant psychiatric disorders (e.g. Belgium, the Czech 
Republic, Spain, Poland). The inclusion of a pre-TC motivational component and a 
community-based component for TC graduates transitioning back into the community 
were identified as new practices in TC programmes in a number of countries (e.g. 
Belgium). In several countries (e.g. Spain, Poland, the United Kingdom), the establishment 
of prison-based TCs is a relatively new phenomenon in the TC treatment arena.
I The current evidence base for therapeutic communties
Over the past three decades, a body of evidence has been developed in support of the 
effectiveness of TC treatment for addictions. In order to review the most recent evidence, a 
literature review was undertaken for this report, drawing on 28 scientific articles reporting 
16 randomised controlled studies or quasi-experiments (all conducted in North America) 
and 21 articles reporting 14 observational studies (conducted in Europe). This review 
suggests that there is some evidence for the effectiveness of TC treatment in terms of 
reduced substance use and criminal activity, at least in the USA. A small number of studies 
also showed positive effects on employment, social functioning and general mental health.
Across the controlled studies in the USA, retention in TC treatment varied substantially. 
Although positive treatment outcomes strongly correlate with treatment completion, TCs 
are overall less effective than other interventions with respect to treatment retention. The 
available evidence suggests that there is an added value for modified — that is shorter or 
less intensive — TC interventions, when compared with the traditional long-term TC 
treatment programmes. Clients retained in TC treatment achieved gains in terms of 
reduced drug use and abstinence and experienced longer periods of drug-free functioning 
post treatment than those given ‘treatment as usual’, no treatment or ‘modified’ TCs.
TC outcome research in Europe is limited to observational studies, and any conclusions 
are necessarily tentative because of a range of methodological limitations. Generally, 
however, these studies report positive treatment outcomes, associated with longer 
retention in treatment and treatment completion, and almost all observational studies 
report that TC residents show reductions in drug use and arrests and improved quality of 
life (social and health domains).
One general conclusion that may be drawn from the US and European review is that 
people in TCs in prison had lower reincarceration rates 12 months after release than 
prisoners receiving no treatment or assigned to alternative services. In addition, reductions 
were identified in measures of re-arrest, reoffending and time to reincarceration which 
were substantially greater than changes in criminal activity achieved by control groups.
I Service standards
The development and implementation of evidence-based clinical guidelines and service 
standards can play an important role in the quality assurance and improvement 
processes in TCs. However, the establishment of appropriate standards for this complex 
and ever-changing therapeutic approach remains a challenge. Standards for TCs may 
need to be less operational than for medically based treatment approaches (e.g. opioid 
substitution treatment) and need to reflect the daily living and learning circumstances of 
residents in TCs.
Executive summary
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Initial and in-service staff training and regular supervision help to ensure the 
implementation of service standards where these are available. However, not all European 
TCs have access to national quality control mechanisms, and opportunities need to be 
taken to develop cooperation and networking between TCs across Europe — to enhance 
both knowledge sharing and the transfer of best practice.
I Future challenges for therapeutic communities
In recent years, the TC ‘community as method’ has been extended to respond to the needs 
of a number of specific populations, and the future of the TC may depend on successful 
targeting of areas where they can have a positive impact at an adequate cost. A growing 
emphasis on expenditure containment is likely to contribute to further reductions in the 
planned duration of TC treatment episodes. In addition, we are likely to see the role of 
informal volunteers and self-help elements increasing at the expense of ‘professional’ staff 
members akin to North American TC programmes. The way the quantity and, more 
importantly, the quality of the TC interventions are negotiated is likely to be the main factor 
determining their future role in addiction treatment.
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I Introduction
The therapeutic community (TC) is one of the longest standing modalities for the 
treatment of drug addiction — dating back to 1958, when Synanon, a community of 
ex-addicts, was founded in Santa Monica (California, USA). The Synanon model quickly 
spread across the USA, giving rise to the first ‘concept’ TC programmes (e.g. Daytop 
Village, Phoenix House, Odyssey House) (Goethals et al., 2011). These drug-free, peer-led 
environments adopted Synanon’s hierarchical structure and therapeutic techniques and 
set a three-stage treatment model (detoxification, treatment, reintegration), applied by 
many residential abstinence-oriented treatment programmes since.
A ‘drug-free’ or ‘concept’ TC, later called TC for addictions (De Leon and Ziegenfuss, 
1986), has been defined as ‘a drug-free environment in which people with addictive 
problems live together in an organised and structured way to promote change towards a 
drug-free life in the outside society’ (Broekaert et al., 1993, p. 55). Not all residential 
treatment programmes are TCs and not all TCs are organised and delivered in a residential 
setting (Broekaert et al., 1999). Moreover, not all programmes self-identified as TC 
programmes employ the same theory, model or method.
The establishment of drug-free TCs in Europe represented the main treatment response to 
the emerging heroin problems in the 1960s and the early 1970s. From the beginning, the 
original American TC model was adapted to European culture, integrating the tradition of 
milieu therapy and elements of a number of psychotherapeutic schools (Broekaert, 
2006a). Between 1968 and 1983, TCs were established across Europe (including Belgium, 
Germany, Greece, Spain, Italy, the Netherlands, Sweden, Switzerland and the United 
Kingdom). Following the fall of the Iron Curtain in the late 1980s, TCs were established in a 
number of former communist countries. However, the growing size of the heroin problem, 
and the advent in the 1980s of the human immunodeficiency virus (HIV) epidemic, 
prompted the introduction and expansion of other tiers of drug treatment responses, most 
notably opioid substitution treatment (OST) and harm reduction interventions.
When compared with the 1980s and 1990s, the availability of TC programmes has 
reduced in Europe. To some extent this may be linked to the relatively high cost of this 
long-term intensive treatment; however, there are also national and cultural factors at play, 
as different countries have shaped unique drug treatment provision landscapes and 
therefore given different degrees of prominence to TC treatment. Chapter 1 of this 
publication introduces TCs from a historical perspective and provides an overview of their 
development in Europe and beyond.
This Insights publication integrates the results from an EMCDDA data collection exercise 
and contributions from key informants from a number of countries (Belgium, the Czech 
Republic, Spain, France, Poland, Sweden and the United Kingdom) where TC treatment is 
available and information about it could be accessed. The aim is to provide a Europe-wide 
overview of treatment provided by TCs, including country-specific features of its history 
and current role in the wider drug treatment systems, as well as exploring the availability 
and diversity of such programmes. This is presented in Chapter 2 through an overview of 
the country-specific features of TC programmes, as well as differences in relation to 
financing and staffing.
While the latest estimates suggest that around 730 000 problem opioid users are 
receiving OST in Europe, at least a quarter of a million drug users are receiving other forms 
of treatment, including drug-free treatment in TCs. Outpatient treatment and rehabilitation 
is not always a realistic option, particularly for a select group of drug-dependent clients 
who need the safety, care and structure that TCs can provide. However, while OST is 
supported by compelling scientific evidence, accumulated over recent decades regarding 
Therapeutic communities for treating addictions in Europe
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the benefits it offers in treating opioid dependence and in improving its associated health 
and social consequences, the evidence base for the effectiveness of TCs is far less well 
developed (Smith et al., 2006; Malivert et al., 2012).
In recent years, more is being done to demonstrate clinical effectiveness as funding 
becomes increasingly linked to evidence. However, applying outcome-based studies to 
TCs is difficult as the TC intervention is holistic and is not easily broken down into separate 
observable components that can be measured quantitatively (unlike pharmacological 
treatments, for example). Thus, applying randomised controlled trial (RCT) methodology to 
TCs is often a challenge. Chapter 3 provides a comprehensive review of the scientific 
evidence for TC treatment, both European and international. Findings are presented, 
grouped by study design and according to country of origin, with a description of the 
methodologies applied. All the evidence derived from RCTs originates from the USA while 
European research on TCs has primarily utilised observational methodologies.
Chapter 4 focuses on the use of clinical guidelines and quality assurance frameworks in 
TC treatment and rehabilitation. These are reviewed with regard to both availability and use 
in TC treatment delivery at national and international levels.
Finally, changing views on addiction as a chronic disorder and emerging theoretical 
insights that question prolonged treatment episodes in closed communities are obliging 
TC practitioners to reflect on the therapeutic objectives and methods of TCs, as well as on 
how treatment outcome is defined and measured. Examples of the perceived added value 
of TCs as part of the available responses to drug addiction, and also examples of 
contemporary challenges in delivering this type of treatment, are highlighted in Chapter 5.
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I 1.1. Introduction
Therapeutic communities (TCs) as a treatment modality 
are found in a variety of populations and settings including 
addicts, as well as children and young people, prisons, 
personality disorders and learning disabilities. The term 
‘therapeutic community’ was first used by the British 
psychiatrist Tom Main (1946) in a description of the 
so-called ‘Northfield Experiments II’ from the Second 
World War, in which soldiers suffering from ‘shell shock’ 
and ‘war neurosis’ were using group processes 
therapeutically (Harrison and Clarck, 1992). From that 
moment onwards, the term ‘therapeutic community’ has 
been linked to a range of treatment traditions and 
approaches that share the ‘idea of using all the 
relationships and activities of a residential psychiatric 
centre to aid the therapeutic task’ (Bridger, 1990, p. 60). 
These treatment traditions are outlined below:
n  TCs for maladjusted children, around the end of the 
nineteenth to the beginning of the twentieth century. 
These communities are associated with the ‘new 
school movement’ (the renewal pedagogues such as 
Célestin Freinet and Edouard Claparède), planned 
environment therapy (e.g. David Wills) and 
psychoanalysis (e.g. Anna Freud) (Bridgeland, 1971);
n  democratic TCs, inspired by the Northfield 
Experiments and developed by Maxwell Jones for the 
treatment of neurotic soldiers during and shortly after 
the Second World War (Jones, 1968; Harrison and 
Clarck, 1992). Jones strongly emphasised the 
importance of changing the hospital structure into a 
more open system facilitating two-way 
communication, decision-making in consensus and 
social learning (Vandevelde et al., 2004);
n  drug-free, concept-based TCs or TCs for addictions, 
originating from Synanon, a non-professional 
community for addicts developed by the American 
Charles ‘Chuck’ Dederich in 1958 (Yablonsky, 1967). 
The central element was the juxtaposition of a 
hierarchical structure with the Game (later the 
‘encounter group’), primarily based on confrontation 
(De Leon, 2000);
n  TCs developed under the impetus of the anti-
psychiatry movement in the 1960s. In anti-
psychiatry, TCs were viewed as alternatives to the 
traditional psychiatric approach to treatment that 
typically aimed to ‘cure’ sick patients (Crossley, 1998, 
p. 878).
The application of the term ‘therapeutic community’ to 
denote treatment for different populations in different 
settings has led to heterogeneity in and a lack of 
consensus concerning definitions and descriptions of 
essential elements and principles (De Leon, 2000).
For the democratic TC tradition, an attempt to clarify this 
heterogeneity was initiated by Clarck (1965) and further 
elaborated by Kennard (1998) — both of whom marked a 
notable distinction between what they called the TC 
‘proper’ and the TC approach. In the former, a specific 
small ward, unit or hospital was designed explicitly to 
make the social environment the main therapeutic tool 
(Clarck, 1965, p. 948). In the latter, the community and 
group methods were not the exclusive means of 
treatment but were applied to create an atmosphere of 
respect for the patient’s individuality, attention to daily 
activities and work, responsibility, and personal 
relationships (Clarck, 1965).
These two origins (TC ‘proper’ and TC approach) help to 
explain some of the variety that has developed in the 
field. First is the difference between the intensive, small, 
inpatient TC ‘proper’ and TC ‘approaches’ to humanising 
whole hospitals (Clarck, 1965). In US terms, the attempt 
to humanise whole hospitals, and to utilise the general 
social environment, has come to be described as ‘milieu 
therapy’ (Schimmel, 1997, p. 121).
The general stream of ‘concept-based’ or ‘hierarchical’ 
TCs, developed in the USA during the 1950s, includes 
the intensive inpatient-type programme, explicitly 
targeted at the addictions, and organised on an explicitly 
non-psychodynamic model of closely monitored and 
highly intrusive social conditioning, designed to get 
people off drugs and to provide a complete break from 
their past lifestyle.
CHAPTER 1
Therapeutic communities: definition, 
history and key characteristics
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other) problems live together in an organized and 
structured way in order to promote change and 
make possible a drug-free life in the outside 
society’  
(Broekaert et al., 1993, p. 55)
‘The fundamental distinction of the therapeutic 
community is that it utilizes “community as 
method” in addressing the substance abuse and 
social and psychological problems of the 
individual’  
(De Leon, 1997, p. 269)
This definition can be expanded as follows:
‘The TC forms a miniature society in which 
residents, and staff in the role of facilitators, fulfil 
distinctive roles and adhere to clear rules, all 
designed to promote the transitional process of 
the residents. Self-help and mutual help are 
pillars of the therapeutic process, in which the 
resident is the protagonist principally responsible 
for achieving personal growth, realizing a more 
meaningful and responsible life, and of upholding 
the welfare of the community. The program is 
voluntary in that the resident will not be held in 
the program by force or against his/her will’  
(Ottenberg et al., 1993, pp. 51–62).
I 1.3. Key features
Central to the above definition and to the TC treatment 
practice is the concept of ‘community as method’ or, in 
other words, the ‘purposive use of the peer community 
to facilitate social and psychological change in 
individuals’ (De Leon, 1997, p. 5). There are, however, a 
number of other defining features of TCs. Table 1.1 
Nonetheless, there are a number of general points that 
encompass the range of TCs. The TC is essentially a 
living learning situation, which means that residents are 
totally immersed in the treatment environment, so that all 
of their daily behaviour and their emotional and physical 
state can be observed and challenged as appropriate 
through intensive group experiences. In addition, they are 
encouraged to experiment with alternative behaviours 
and corrective emotional experiences. Thus, Roberts 
defines the TC as ‘a consciously-designed social 
environment and programme within a residential or day 
unit in which the social and group process is harnessed 
with therapeutic intent (Roberts, 1997, p. 4). In the TC, 
the community is the primary therapeutic instrument.’ 
(De Leon, 2000, p. 93).
This publication specifically focuses on concept TCs or 
TCs for the treatment of addictions, and henceforth the 
two terms are used interchangeably. TCs for addictions 
are defined in a subsequent section and the latter part of 
this chapter focuses on the TC treatment model and its 
key features. This chapter concludes with a short review 
of the history and development of TCs in Europe.
I 1.2. Definition
As noted above, a number of definitions for TCs have 
been put forward in the literature, which clearly reflects 
work in progress with regard to achieving consensus on 
what could be termed a TC.
For the purposes of this Insights publication, the 
following integrative definition of TCs for the treatment 
of addictions will be used:
‘A therapeutic community is a drug-free 
environment in which people with addictive (and 
TABLE 1.1
Key features of therapeutic communities (TCs)
Concept TCs Democratic TCs
Self-help The resident is the protagonist of his own 
treatment. Other residents can act only as 
facilitators
Permissiveness Residents can freely express thoughts and 
emotions without any negative repercussions
Hierarchy Daily activities take place in a structured 
setting where residents act as role models
Democratisation All staff and residents participate equally in 
the organisation of the community
Community Living together in a group and fostering 
belonging is the main agent for therapeutic 
change and social learning
Communalism Face-to-face communication and free 
interaction to create a feeling of sharing and 
belonging
Confrontation Residents present to each other feedback 
— observations of, and reactions to, 
behaviours and attitudes that interfere with 
community rules, value and philosophy and 
which should be changed
Reality testing Residents are continually confronted with 
their own image as perceived by other 
residents and staff
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Theory: TCs are characterised by a specific view on how 
to understand addiction. It is certainly not seen as a 
disease, but rather as a problem of the ‘whole person’. 
From that point of view, treatment has nothing to do with 
the ‘drug’, but rather concentrates on the ‘person’ him- or 
herself (De Leon, 1997, p. 9). This point of view is 
reflected in the TC philosophy — based on early 
Christian values, the Oxford groups, Alcoholics 
Anonymous, Synanon and the humanistic psychology 
— that highlights the belief in the resident’s potential 
and personal growth (Broekaert, 2001). The person is 
considered as emotionally frail and immature, but with 
the potential to change positively. In order to stress that 
people can be educated and do not have to be cured, 
TCs speak about ‘residents’ rather than ‘patients’ 
(Broekaert, 2001). In a TC, residents are expected to 
strive towards ‘right living’ or a positive lifestyle, in 
accordance with the TC philosophy. Right living includes 
values such as honesty, responsible concern, dedication, 
work ethic and the consideration of learning as a main 
value (De Leon, 2000). Recovery is not used in the 
traditional medical way (i.e. becoming abstinent), but 
rather as an indication of a more fundamental change in 
identity and lifestyle (De Leon, 2000).
Model: The essential elements of a generic TC model 
include aspects such as the community’s physical 
environment, the social organisation, work as therapy 
and education, TC staff members, peers and their roles 
in the TC, relationships and programme stages.
A TC programme typically consists of three stages: an 
induction phase (1–60 days); a phase of primary 
treatment (2–12 months); and a re-entry phase (13–24 
months). In some, but not all, TCs, these phases are 
further structurally refined into the following stages: 
crisis intervention, ambulatory induction, reception, 
induction, treatment and social (re-)integration 
(Broekaert, 2001). When going through the stages, TC 
residents gradually gain more responsibilities and 
privileges. Furthermore, several stages with regard to the 
residents’ internalisation of change can be discerned, 
evolving from compliance over conformity and 
commitment towards integration. Eventually, this leads 
to true identity change (De Leon, 1994, 1995, 2000).
The TC’s physical environment, which reflects 
consistency and predictability, contributes to the 
residents’ change process. The following basic rules 
ensure an environment of trust and safety in every TC 
programme: no drugs or alcohol, no violence and no 
sexual relationships. With regard to the social 
organisation, the pyramidal structure of hierarchy is 
important. Work activities are an essential part of TC 
treatment, and the process of working, which results in 
summarises the key features of both concept (drug-
free, hierarchical TCs for the treatment of addiction) 
and democratic (Maxwell Jones-type) TCs, both of 
which are included in the TC definition applied to this 
publication.
Despite the various origins of application of the term 
‘therapeutic community’, there are some commonalities 
and generic aspects that are quintessential for TCs from 
the different branches set forth in the introduction. 
Glaser (1981), for instance, notes that a key feature of 
both addiction TCs and democratic TCs is that residents, 
in collaboration with the staff, become active 
participants in their own therapy and that of other 
residents and in the general conduct of the entire 
programme. Others have put forward the hypothesis of a 
‘generic’ model underlying TCs throughout the world (for 
a review, see Goethals et al., 2011, Chapter 5) or shared 
perspectives, including the following seven 
characteristics (Kennard, 1994, cited in Whitwell, 
1998, p. 76):
‘a group of people living together; intimate, 
informal relationships; regular and frequent 
sharing of information between all group 
members; a shared commitment to the goal of 
learning from the experience of living and/or 
working together; a shared commitment to the 
open examination and resolution of problems, 
tensions and conflicts within the group; a 
psychodynamic awareness of individual and 
group process and a clear set of boundaries 
concerning time, place and roles’.
Broekaert (2001, p. 29) adds the following core elements 
‘which cannot be changed in a TC’: a striving for 
integration in the wider community; everybody (both 
staff and clients) should be open to challenge and 
confrontation; ex-addicts can be considered as role 
models; staff should act according to ethical standards; 
and the duty to review their mission and vision on a 
regular basis.
I  1.4. The theory, model and method of the therapeutic community
De Leon (2000) makes a distinction between the theory, 
model and method of TCs. The theory concerns the TC 
perspective on how to view the disorder, the person, 
recovery and right living. The model consists of the 
generic programme components and the method can be 
described as ‘community as method’ (De Leon, 2000).
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three times a week and last for about two hours. 
Residents (in mixed groups of 8 to 10 people) are 
required to confront the negative behaviour or attitudes 
of their peers. Because TC members are asked to ‘act as 
if’ they have no problems during their stay in the TC, the 
built-up tension leads to intense expressions of emotion 
during encounter groups. It can be considered as a tool 
for social learning, leading confronted residents to new 
insights into themselves and to identification with values 
of ‘older’, more experienced residents (Broekaert, 2001).
I  1.5. Overview of therapeutic community history in North America and Europe
Several studies have outlined the historical roots of TCs 
(e.g. De Leon, 2000; Vandevelde et al., 2004; Broekaert 
et al., 2006) and have differentiated three distinct 
generations of TCs.
I First generation (early 1950s)
The first generation can be described as the democratic 
TCs, which were inspired by psychoanalytical thinking 
(e.g. the Northfield Experiments) and sociotherapy/social 
learning (e.g. Jones, 1953). Haigh and Lees (2008, p. 353) 
identified that this model, which is sometimes also called 
the British tradition, is primarily concerned with ‘the 
format of therapy — in groups and with a particular nature 
of relationships and democratic procedures — rather than 
a specific theoretic orientation’.
I Second generation (late 1950s to early 1960s)
The second generation involves the US tradition, which 
began with Synanon in 1958. Synanon was founded by 
a recovered alcoholic named Charles ‘Chuck’ Dederich. 
It was set up as a Utopian idealistic micro-society 
where recovering addicts lived and worked together, 
adhering to values such as truth, honesty, creativity, 
openness and self-reliance (Broekaert et al., 2000; 
Janzen, 2001). Dederich was inspired by the idealistic 
writings of R.W. Emerson, early Christian values, 
Eastern philosophy, moral re-armament (the ‘Oxford 
groups’, led by Frank Buchman) and Alcoholics 
Anonymous (AA) and its 12-step method (Broekaert et 
al., 2006, p. 2).
The 12-step method initiated by AA is one of the most 
widely used mutual aid models in addiction treatment 
personal growth, is more important than the ‘material’ 
results that are realised. The structure is reflected by 
daily routine and the organisations in service 
departments (kitchen, administration, laundry), each of 
which have their own internal hierarchy. Residents move 
from having little or no responsibility to becoming 
department heads or even the co-coordinator of the TC.
The TC is organised according to a daily regimen, during 
which residents and staff members are expected to 
share meals and attend meetings, such as the 
community meeting (De Leon, 2000). Every day starts 
with the community meeting, followed by morning 
activities, lunch, free time, afternoon activities, dinner, 
and some free time before going to bed. The primary 
goal of the community meetings is to strengthen 
community feeling and cohesion (De Leon, 2000).
Peers play a very important role with regard to the social 
learning process in TCs (De Leon, 2000). They are 
considered ‘role models’ who give the right example by 
living according to the TC’s philosophy and value system. 
In this respect, Broekaert (2001, p. 37) describes TC 
treatment as ‘an intensified form rebuilding a value 
system, one that uses old principles of therapeutic 
education and social learning, and adapts them to the 
needs of the drug-abusing population’.
Interpersonal relationships, both inside and outside the 
programme, are used to support the process of change. 
Residents can learn skills to communicate with and 
relate to other people in a safe environment. Family work 
is considered an essential element of TCs and efforts are 
made to involve family members and prepare clients for 
meeting their relatives (Broekaert, 2001).
Method: Although essentially all activities and 
interactions contribute to recovery, the ‘daily regimen of 
structured activities, is viewed as methods’. Community 
as a method is identified as the quintessential element, 
with the following basic components, among others: a 
community environment, with a range of community 
activities and peers as role models; a structured day, in a 
phase format, with work as therapy and education; peer 
encounter groups; and a planned duration of time (De 
Leon, 1994, pp. 24–27). During the day, seminars, 
encounter groups and other therapeutic sessions are 
organised. If residents display ‘acting out’ behaviour, they 
are corrected by staff or coordinators by means of verbal 
reprimands or learning experiences. These must not be 
confused with mere ‘sanctions’, as these reprimands or 
learning experiences are meant to support the resident.
Encounter groups are the central element of TC 
treatment. These non-hierarchical meetings take place 
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and the resistance to involving trained professionals 
(O’Brien, 1993).
I Third generation (late 1960s to 1980s)
From the 1960s and 1970s onwards, TCs were 
developed in several countries throughout Europe, an 
evolution that can be regarded as the third generation of 
TCs. European countries in which TC programmes were 
founded at that time included the United Kingdom (e.g. 
Phoenix House — Alpha House; Featherstone Lodge 
Project; Phoenix House; the Ley Community), Italy (e.g. 
L’Incontro; San Patrignano; CeIS), Germany (e.g. Klinik 
Bad Herrenalb; Synanon; and Daytop Germany), 
Switzerland (e.g. Le Centre du Levant; Aebi Hus) 
(Kooyman, 2001), the Netherlands (e.g. Emiliehoeve) 
(Kooyman, 1992), Sweden (e.g. Vallmotorp Daytop) 
(Möller Teppema, 1984), Ireland (e.g. Coolmine Lodge) 
(Cullen, 1987), Belgium (e.g. De Kiem; De Sleutel; 
Trempoline; De Spiegel) (Broekaert, 1981; Maertens, 
1999) and Finland (e.g. Pellas Community; Kisko). In the 
1980s, TCs were founded in Spain (Programmas Libres 
de Drogas), Norway (Phoenix House), Greece (Ithaka/
Kethea) (Broekaert et al., 2006) and some east European 
countries (e.g. Poland and the Czech Republic) after the 
fall of the Iron Curtain (see Chapter 4).
The beginnings of third generation TCs in the 1960s and 
1970s took place in a period characterised by an 
emerging incidence of heroin addiction in several 
European countries. The increased availability of heroin 
and other illicit substances and the lack of effective 
responses led to a heroin epidemic in the mid-1980s. 
This resulted in the rapid spread of infectious diseases, 
mainly HIV/AIDS, and caused a dramatic growth in the 
number of drug-related deaths caused by drug 
overdoses. Injecting heroin, in particular, led to a 150 % 
increase in drug-related deaths between 1985 and 1995 
(Hedrich et al., 2008). While most European countries 
(including Belgium, Germany, Greece, France and the 
Scandinavian countries) applied an abstinence-oriented 
drug treatment approach until the 1990s, the 
Netherlands, the United Kingdom and Switzerland 
embraced the harm reduction approach for reducing the 
negative health and social (e.g. crime) consequences of 
drug use from the 1980s onwards (Hedrich et al., 2008).
Around this time, TCs started to lose their dominant 
position in treating drug users. TCs faced many 
challenges in the 1990s, such as financial cutbacks as a 
result of the economic crisis, questions about the high 
dropout and relapse figures and changing drug policies 
primarily aimed at reducing drug-related harm. Problems 
with charismatic leadership in some TCs (e.g. in ‘Le 
around the world (Magura, 2007). It has been adapted 
into the Minnesota model treatment — regarding 
addiction as disease, the professionals practising the 
model address the physical, psychological and spiritual 
aspects of addiction. The National Institute on Drug 
Abuse (NIDA) describes the goals and objectives of the 
Minnesota model as lifetime abstinence by following the 
12 steps leading to recovery. Despite the historical link 
between TCs and AA, there has not been much research 
published on the connections between TCs and 12-step 
programmes (Troyer et al., 1995). While in some 
countries (e.g. the Netherlands, Sweden), many long-
term residential programmes apply the Minnesota or 
12-step model, these concepts should be differentiated 
from TCs as analysed in this publication.
An important difference between TCs and 12-step 
programmes is the fact that TCs do not refer to addiction 
as a disease. On the contrary, rooted in the humanistic 
psychology — characterised by a genuine belief in 
growth and the ‘human potential’ — the development of 
TCs could be regarded as a reaction against the medical 
model of addiction (Troyer et al., 1995). Furthermore, TCs 
do not refer in their concept to a ‘higher power’ as AA 
does in four of its 12 steps (Galanter, 2007). Another 
difference lies in the fact that confrontation (which 
presupposes that addicts should be considered 
responsible persons), a central element of the encounter 
groups in TCs, is not characteristic of AA or other 12-step 
programmes. More differences are described by De Leon 
(2000): the non-residential settings of AA versus the 
residential setting of TCs; the more severe client profile of 
TCs in comparison with AA; and differences in treatment 
objectives — becoming ‘clean’ (AA) versus a lifestyle 
change (TCs). Yet, although AA and TCs are clearly 
distinct, there seems to be a growing recognition from 
both sides of the complementary value of both treatment 
approaches. In some American TCs, 12-step programme 
components are increasingly being linked with TC 
treatment as a form of aftercare (Troyer et al., 1995).
Within six years of its development, Synanon had laid 
the basis for a number of TC programmes, including 
Daytop Village (1964) and Phoenix House (1967). This 
could be explained by Synanon’s positive effects on the 
life of heavily addicted persons — a result not being 
achieved at that time by the traditional psychiatric 
hospitals, which failed to successfully treat addiction 
(Kooyman, 2001). This second generation of TCs was 
essentially behaviouristic, yet grounded in the American 
humanistic tradition. The TC movement eventually broke 
with Synanon for several reasons: the coerced lifelong 
commitment to the community, which evolved into a cult 
with Dederich as the charismatic leader; the use of 
sometimes hard learning and disciplinary techniques; 
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such as cultural differences, political priorities, economic 
grounds and social policy options (Broekaert et al., 
2000). Although essentially inspired by the US TCs, 
European TCs clearly have their own identity; the 
behaviouristic approach of US TCs has been 
complemented by European educational theories, 
psychoanalytical thinking, social learning, the 
involvement of trained professionals (instead of 
recovered ex-addicts serving as staff members) and a 
more family-oriented approach (Broekaert et al. 2006). 
There was also strong opposition in Europe to the hard 
learning techniques such as wearing signs and shaving 
hair — the so-called haircuts — and the extremely harsh 
confrontations in encounter groups (Goethals et al., 
2011). This led to a European TC model that focused on 
a more balanced dialogue during encounter groups 
(Broekaert et al., 2004). TCs from various European 
countries today are collaborating in the European 
Federation of Therapeutic Communities  
(EFTC; http://www.eftc-europe.com/) and the World 
Federation of Therapeutic Communities  
(WFTC; http://www.wftc.org/).
Over the last 50 years, the TC has evolved from a 
long-term, generic treatment model to a modified and 
shortened model (modified TC) that is better tailored to 
the needs of specific groups of drug users, e.g. women 
with children, detainees and individuals suffering from 
other psychiatric disorders and that seeks to integrate 
evidence and belief in change (Goethals et al., 2011). 
Although the TC started as a belief-based treatment 
modality, building on a hierarchical structure, self-help 
principles and encounter groups as core therapeutic 
features, not inconsiderable attention has been given to 
the scientific underpinning of the method.
Patriarche’, France) and the switch from self-funded, 
independent organisations to mainstream services that 
are funded and controlled by the government led to the 
closure of some TCs and their replacement with smaller 
communities run by professionals instead of ex-addicts. 
More recently, the changing view on addiction as a 
chronic disorder and increasing criticism on the benefits 
of lengthy treatment episodes in closed residential 
settings by scientists, client advocates and service users 
have further challenged the development of TCs in many 
countries. The evidence-based paradigm that applies the 
randomised controlled trial (RCT) as the ‘gold standard’ 
for evaluating interventions has even questioned the 
validity of TCs, as they usually score low on ‘evidence-
based’ rankings (Broekaert et al., 2010).
These challenges and evolutions have contributed to a 
decrease in the number of TCs in many European 
countries such as the Netherlands, Sweden, Switzerland 
and the United Kingdom (Broekaert and 
Vanderplasschen, 2003). To cope with these challenges, 
TCs have become more open towards harm reduction 
initiatives (e.g. introduction of methadone maintenance 
treatment modified TCs) and integrated elements from 
mainstream drug treatment and have become part of 
integrated treatment systems. Moreover, several TCs 
have been scaled down to smaller units or modified to 
meet the specific needs of subgroups of drug-using 
persons, such as women with children, dually diagnosed 
persons and prisoners.
I Therapeutic communities in Europe today
The divergent implementation of the TC as a treatment 
modality across Europe is influenced by various factors 
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This chapter presents an overview of the availability and 
implementation of therapeutic community treatment for 
addictions in Europe, featuring historical and current 
developments and national case studies.
CHAPTER 2
The availability of therapeutic 
communities in Europe
Data were sourced from national stakeholders and 
other expert sources. Key informants were: 
programme directors or other individuals with a 
strategic overview of TC treatment provision at 
national level, who were also associated with the 
European Federation of Therapeutic Communities 
(EFTC), and the EMCDDA's network of national focal 
points (NFPs) in cases where EFTC contact did not 
exist or did not respond to our request. Other key 
sources included relevant chapters of the national 
reports provided by NFPs to the EMCDDA over the 
past five years. The aims were to identify the 
availability and capacity of TC treatment in all EU 
Member States, Turkey and Norway; and to identify 
historical developments and current aspects of TC 
treatment delivery and practice in a selection of 
European countries (Belgium, the Czech Republic, 
Spain, France, Poland, Sweden, the United Kingdom). 
An EFTC-network contact was not available or 
responsive in eight countries (Estonia, Croatia, Latvia, 
Luxembourg, Malta, Romania, Slovakia and Turkey); 
and in these countries, EMCDDA NFP contacts 
collaborated and provided data.
Twenty-eight of the 30 EMCDDA Member States 
reported data (Germany and Croatia being the 
exceptions). Data sources were the national country 
reports (if data on TC provision were reported 
separately) or the EMCDDA NFP contact person in 15 
countries. In 13 countries (Belgium, Bulgaria, 
Denmark, Finland, France, Hungary, Ireland, Italy, the 
Netherlands, Norway, Poland, Sweden and the United 
Kingdom), data were provided by national TC experts 
(usually TC directors). As data for the present study 
were sourced from beyond the Reitox NFPs network, 
in some countries the number of TC programmes 
identified differed from those provided in a companion 
report (EMCDDA Paper on residential treatment, in 
press). In some countries, TC is not officially 
recognised as a treatment modality, leaving it open to 
the national TC experts whether or not treatment 
facility is considered as providing TC interventions. 
Facilities that were not acknowledged by the national 
health or social authorities (e.g. religious communities) 
were not included in this number.
The number of treated clients per year is based on 
official records in all cases except Poland, where an 
estimation was provided. This number should 
represent the number of persons who have reportedly 
followed TC treatment for at least one day that year. 
For this study, 2011 was chosen as the year of 
reference, although for some countries the target 
information was not available at the point of data 
collection; data provided here present the most recent 
official data for each country.
The single integrative definition of TC as provided in 
Chapter 1 has been used to access and analyse the 
information presented.
Methodology
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the TC capacity in some large countries (e.g. Germany, 
Spain, Italy), the total capacity and number of treated 
cases can only be estimated. If the average capacity of 
TC programmes in Italy is set at six (the known capacity 
of a large number of small units) and in Spain is based 
on the EU average of 20, the number of places for drug 
addicts in TC programmes in Europe can be estimated to 
be over 15 000 beds (Table 2.1).
The estimated number of TC clients per year in each 
country is indicative of the turnover and average 
treatment duration in these countries. However, not all 
key informants were able to provide this information. In 
most countries, the duration of a TC treatment 
programme is between 6 and 12 months and the 
number of clients (persons retained in the TC for at least 
one night) per year is twice the available capacity. In 
some countries, this rate is considerably higher (e.g. 
Poland, Finland), owing to a high client turnover and/or 
the short length of (some) TC programmes. The low 
client turnover in other countries (e.g. Belgium, Cyprus, 
Ireland, Luxembourg) may be caused by high retention 
rates and adequate induction strategies to prepare drug 
addicts for TC treatment. It cannot be ruled out, however, 
that some of these differences were partially caused by 
the lack of standardisation in data collection between 
countries (e.g. registration of all intakes vs. only those 
who stayed at least one night).
Taking into account the different population sizes, the 
number of facilities offering TC per one million adult 
inhabitants was calculated (Table 2.1). A comparison 
between the number of facilities per one million adult 
population in each country reveals that proportionally 
the largest number is found in Malta and Italy (18 and 
13, respectively), followed by Lithuania (6), Portugal (5), 
Slovakia (4) and Spain (3).
I  2.1. Therapeutic communities in Europe today
In total, over 1 200 TC programmes were identified 
throughout Europe; only in Turkey was the TC as a 
treatment method not applied. Detailed information on 
the number of treatment facilities providing TC 
interventions in each Member State is provided in Table 
2.1. Two-thirds of these programmes were reported from 
Italy (n = 798) — with the Italian experts describing most 
of these programmes as small, family-type structures 
with a capacity of four to six residents, but adhering to 
international TC guidelines and standards (Andrea 
Ascari, personal communication, 19 April 2012). Outside 
Italy, just over 400 treatment facilities providing TC 
interventions were identified. While the number of TC 
programmes is low (fewer than five) in the majority of 
countries, it seems to be a well-established treatment 
modality in south (e.g. Greece, Spain, Italy, Portugal) and 
some east European countries (e.g. Lithuania, Hungary, 
Poland), with a total of 15 countries reporting five or 
more TC programmes.
Key informants in several European countries reported 
considerable problems for these programmes in terms 
of public funding for their work, resulting in the shutdown 
of some TC programmes (e.g. Norway, the United 
Kingdom) or a reduction in treatment duration (e.g. 
Czech Republic, Spain, Finland) or number of beds per 
unit (e.g. Latvia, Sweden). France is a clear exception in 
this sense, as the provision of TCs for addictions has 
been recently re-established (see section 2.2.2). The 
capacity of these programmes varies greatly, but is 
usually between 15 and 25 residents each. In some 
countries, the number of treatment slots per unit is 
clearly higher (e.g. Cyprus, France, Poland, Portugal, 
the United Kingdom). Owing to missing information on 
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TABLE 2.1
Therapeutic community treatment provision in Europe (in 2011, unless otherwise specified)
Country
Reported  
by NFPs (1)
Reported by TC experts 
Number of 
programmes 
Number of 
programmes
Total 
capacity (2)
Number of 
clients per 
year
Average 
number of 
clients per 
programme
Number of 
treated 
clients per 
bed per year
Number of 
programmes 
per one 
million 
population
Belgium 14 8 204 357 25 1.75 0.7
Bulgaria 2 3 60 140 20 2.33 0.4
Czech Republic  18 (3) 10 160 394 16 2.46 1.0
Denmark 14 1 15 41 15 2.73 0.2
Germany 0 n.a. n.a. n.a. n.a. n.a. n.a.
Estonia 1 1 26 82 26 3.15 0.7
Ireland 13 2 45 75 22 1.67 0.4
Greece (4) 6 11 417 980 38 2.35 1.0
Spain 131 129 n.a. 8 134 n.a. n.a. 2.7
France 11 11 380 n.a. 34 n.a. 0.2
Croatia 30 n.a. n.a. n.a. n.a. n.a. n.a.
Italy 708 798 n.a. n.a. n.a. n.a. 13.2
Cyprus 1 1 50 86 50 1.72 1.3
Latvia 3 2 6.5 14  3 2.15 0.9
Lithuania 15 19 330 620 17 1.88 5.9
Luxembourg (4) 2 1 25 44 25 1.76 2.0
Hungary (5) 10 14 374 738 27 1.97 1.4
Malta 3 7 129 360 18 2.79 17.5
Netherlands 4 8 262 555 33 2.12 0.5
Austria 0 9 269 599 30 2.23 1.1
Poland 59 85 2 852 10 000 34 3.51 2.2
Portugal 68 57 1 977 3 584 35 1.81 5.4
Romania 5 3 25 n.a.  8 n.a. 0.1
Slovenia 7 4 112 n.a. 28 n.a. 2.0
Slovakia 13 19 347 857 18 2.47 3.5
Finland 0 4 58 264 14 4.55 0.7
Sweden 0 1 11 27 11 2.45 0.1
United Kingdom 18 10 454 851 45 1.87 0.2
Turkey 0 0 0 0  0 0 0.0
Norway 4 5 123 323 25 2.63 1.0
Total 1 160 1 223 8 449.5
n.a.: not available.
(1)  Data on TC programmes reported in this publication are sourced from beyond the Reitox NFPs. In most countries, a different number of TCs in each 
country was reported in the context of a project focused on residential treatment in Europe and informed by the Reitox network of NFPs (EMCDDA 
Paper on residential treatment, in press). The results from the two different data collections are presented in separate columns; the figures reported by 
TC experts are used in the present analysis. For Germany and Croatia data have been reported only by the NFPs.
(2) Estimation.
(3) Czech Republic: reporting range: [15–20, n = 18].
(4) 2010 data.
(5) 2008 data.
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Jones, Tom Main and others in the development of 
so-called ‘democratic’ TCs during and shortly after the 
Second World War has been described in some detail 
(Kennard, 1983; Kooyman, 2001). These developments 
were significant elements of broader changes within 
psychiatric treatment as a whole, including the 
introduction of psychotherapy and pharmacological 
treatment. In the 1960s, the Scottish psychiatrist R.D. 
Laing took the then remarkable step of moving his 
patients out of the psychiatric hospital altogether and 
establishing the anarchic TC, Kingsley Hall. In earlier 
years, Homer Lane (before the First World War) and 
David Wills (between the two world wars) developed the 
first TCs for ‘maladjusted’ children, including 
confrontational group work and a focus on self-
governance. These developments in psychiatry and 
youth care may have eased the establishment of the 
early addiction TCs, as they began to be imported into 
Europe in the early 1970s, and ensured that these 
apparently new ideas were accepted more readily than 
might otherwise have been the case.
These new TCs soon began to exert an influence upon 
the field of drug treatment in the United Kingdom. By the 
mid-1970s, concept-based TCs accounted for almost 
half of the residential rehabilitation beds in the United 
Kingdom (Yates, 1981). Although this is an impressive 
‘territorial’ claim, in terms of numbers of drug users 
presenting for treatment, TCs were actually a relatively 
small player, as residential treatment was a peripheral 
component of the UK treatment response and the 
numbers of individuals actually treated were relatively 
modest. However, their influence was felt throughout the 
treatment field. By the mid-1970s, medical staff working 
in drug dependency units were beginning to incorporate 
some of the techniques of TCs into the clinical setting. 
The aim was to provide a more therapeutic regime than 
the sterile interaction that had developed, which was 
largely dominated by staff–patient manipulation around 
dosage and type of substitute prescription (Mitcheson, 
1994). Non-residential treatment services, were also 
influenced by TCs, with some developing pre-entry 
‘induction programmes’ (Strang and Yates, 1982), while 
others began to undertake group work modelled upon 
that found in TCs.
Despite their early promise and radical approach, TCs in 
the United Kingdom were slow to adapt to the changing 
demography as the number of drug users began to 
escalate at the end of the 1970s (Yates, 1992). With the 
increase in drug users came an expansion in drug 
treatment services, and TCs struggled to have an 
influence in what was now a substantial treatment field 
dominated by community-based services. This changing 
emphasis towards outpatient or ambulatory treatments 
I  2.2. Development and current therapeutic community practices in selected EU countries
The above-mentioned figures (Table 2.1) reflect the 
present-day situation, which may not be representative 
of the situation in the past. Some countries have had a 
tradition of TCs for more than 30 years (e.g. Belgium, 
Spain, Italy), while other countries have closed down 
several TCs (e.g. the Netherlands, Sweden) or 
transferred them to correctional settings (e.g. Spain, the 
United Kingdom). In most east European countries, TCs 
for addictions were implemented only after the fall of the 
Iron Curtain (e.g. Bulgaria, Hungary), while France 
reintroduced TCs after the closure of the patriarch 
communities in the 1980s.
Consequently, seven countries have been selected that 
represent different positions along the continuum of 
implementation of TCs in Europe: Belgium, the Czech 
Republic, Spain, France, Poland, Sweden and the United 
Kingdom. In each country, history, current practice, 
position in the network of services, staffing, quality 
control, funding and certification were studied, and 
recent challenges and trends regarding treatment in TCs 
for addictions were identified. First, the TC situation in 
each of the selected countries is presented. The seven 
case studies are then compared and critically analysed 
from a European perspective on the history and future of 
TCs for addictions. Information on these country studies 
was based on EMCDDA country reports from 2000 to 
2010 and contacts with TC experts in each country. The 
case studies are presented in the historical order of 
implementation of drug-free TCs: the United Kingdom, 
France, Sweden, Belgium, Spain, Poland and the Czech 
Republic.
I 2.2.1. TCs in the United Kingdom
History
To understand the impact that concept-based TCs have 
had upon other UK drug treatment modalities, it is 
important to understand not only the general mood and 
nature of those other services at the time of their 
transposition but also the changes that had been seen in 
the treatment of the mentally ill and the socially 
dislocated during the previous decades. In post-war 
United Kingdom, drug addiction was viewed as a US 
disease that would, presumably, respond to US 
treatment regimes (Yates, 2011). The work of Maxwell 
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Treatment Agency’s annual report in 2007, which 
appeared to show that only 3 % of the treatment 
population was leaving treatment drug-free (Ashton, 
2008). In addition, the interest in recovery has been a 
grassroots movement, led by service users themselves 
expressing their disenchantment with a treatment 
regime that appeared to place a higher priority on 
infection control and reductions in offending than on 
their aspirations to achieve abstinence-based recovery.
I 2.2.2. TCs in France
History
The 1970s saw the establishment of concept-based TCs 
for the treatment of addiction in Europe. During this 
period TCs in France took up a particular position. After 
living in camps and prisons for five years, Lucien 
Engelmajer, later called the Patriarche, a Jew who was 
ready to become a rabbi, began supporting vulnerable 
groups of people. He started taking care of children of 
deported and executed parents, searching for foster 
homes, and organising living and vacation centres 
(Engelmajer, 1984, p. 13). He later began working with 
drug addicted persons, and, together with his wife Rena, 
a school teacher, created a living centre for addicted 
people at ‘La Boère’ in Saint-Paul-sur-Save. In 1974, with 
the support of Professor Claude Olievenstein, a 
psychoanalytically oriented psychiatrist, Engelmajer 
started ‘l’Association Le Patriarche’ (Wikipedia, 2012).
La Boère offered its residents a daily life routine based on 
work and arts and crafts activities, striving for a balance 
between freedom and responsibility. The ‘direction 
départementale des affaires sanitaires et sociales’ 
supported the organisation with a daily contribution of 
EUR 40 per person (Engelmajer, 1984, p. 200). Starting 
as a small organisation, it soon became larger. In 1984, it 
already numbered more than 100 centres in Europe 
taking care of 5 000 addicts (Arcas, 2010). In 1983, the 
rise of the AIDS epidemic led to the start of ‘Espaces de 
santé pour les séropositifs’, which underpinned the 
further financial support by the administration (Vernette 
and Moncelon, 1996). At the end of the 1980s, the 
organisation numbered 5 000 residents in 210 centres 
located in 17 countries, including North, Central and 
South America (Dianova, 2012).
While the concept-based TCs inspired by the US 
Phoenix House and Daytop models were blossoming in 
other parts of Europe, in France social workers opposed 
the US methods based on strict hierarchy, sanctions, 
echoed wider developments in UK psychiatry and social 
welfare. Increasingly, throughout the 1980s, the trend 
was away from large inpatient psychiatric hospitals and 
towards a range of treatments in the community.
Current practice
Owing to the spread of HIV/AIDS, the new political 
imperative was harm reduction rather than recovery, and 
TCs found themselves on the margins of the debate. This 
increasing marginalisation was reinforced by changes in 
the UK public funding of care which transferred the 
responsibility for authorising payment for residential 
care away from the UK-wide social security system and 
placed it in the hands of local government officials. This 
left TCs — which, in the United Kingdom, had 
traditionally served a geographically diverse population 
— negotiating per capita funding with a large number of 
local authorities that were only too aware that the purse 
was limited and that other causes needed to be funded 
from within the same allocation. As a result, most TCs in 
the United Kingdom found themselves under pressure to 
shorten programme lengths, abandon practices with 
which some funders were uncomfortable, and ensure a 
higher ratio of ‘professional’ staff. At present, there are 
10 TCs that have a total capacity of 454 residents. 
Paradoxically, during the same period, TCs began to be 
explored by treatment planners within the UK prison 
system, as there is good evidence for TC interventions in 
custodial institutions (Inciardi et al., 2004).
Recent evolutions and future challenges
In order to ensure their continued existence and integrity 
in the future, TCs will need to target those areas where 
they can make the most impact and achieve the most 
good. This means designing modified TCs for particularly 
vulnerable populations, such as the homeless and those 
with co-existing disorders, and establishing TCs in areas 
where they are likely to attract a higher proportion of 
their traditional client group, such as in prisons and 
detention centres. It also means TCs working to 
reposition themselves as a ‘senior partner’ in the 
growing UK recovery movement.
The past five years in the United Kingdom have seen a 
resurgence of interest in recovery as a central focus of 
addiction interventions. In part, this has grown out of a 
sense of dissatisfaction among the media, policymakers 
and service planners with the limited objectives of 
current mainstream addiction treatments. This was 
perhaps best exemplified by the public debate that 
followed the BBC’s challenging of the National 
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approach, away from the charismatic-type leadership 
features that were once typical at ‘Le Patriarche’.
I 2.2.3. TCs in Sweden
History
Since the mid-1960s, Sweden has faced a drug problem, 
the initial response to which included medical treatment 
provided within psychiatric units. In the early 1970s, TC 
programmes began to be established, which coincided 
with a general expansion of the whole drug treatment 
and care system, prompted by the AIDS epidemic.
Boekhout van Solinge (1997, p. 122) noted: ‘Of the 
different forms of drug treatment, therapeutic 
communities have for a long time been the most 
dominant. Communities are based in the rural areas of 
Sweden, where it was not uncommon for a drug addict to 
spend a period of two years. Many of the treatment 
institutions are non-governmental: 65 % of all institutional 
care is privately run. This implies they have to sell and 
market their services to the government institutions, 
either at the national level (the Board of Health and 
Welfare) or at the local level (the social services).’
At the heart of the Swedish ideal for a perfect society 
sits a drug-free life, and welfare formed fertile ground 
for the development of the TC philosophy and 
programmes. In 1973, Lars Bremberg founded 
Vallmotorp, on a professional and sociopedagogical 
basis. It was located in Katrineholm, west of Stockholm. 
It functioned on the basis of transactional analysis, 
Gestalt therapy and Maxwell Jones’ democratic TC 
approach (Broekaert et al., 2006). The TC was 
supervised by external experts in transactional analysis 
therapy (Johnson, 2011), a humanistic psychology 
approach that functioned as the bonding force of the 
educational process. Vallmotorp comprised a varied 
staff: psychologists, educators, social workers, teachers, 
and ex-addicts and other non-professionals with life 
experiences. In Vallmotorp, residents were called 
‘students’ and Lars Bremberg ‘rector’, to emphasise that 
Vallmotorp was a school for life.
In 1980, Lars Bremberg created the ‘Daytop Sweden 
Foundation’. Daytop Sweden was directly influenced by 
Daytop New York. In contrast with Vallmotorp, Daytop 
Sweden was a hierarchic drug-free concept TC and 
grouped together with Ribbinglund Hospital and other 
TCs (Broekaert et al., 2006). Subsequently, in 1985, the 
Nordia foundation was established as the first Finnish-
humiliations and mechanistic approaches (Castagné, 
2006).
‘L’Association Le Patriarche’ survived by the profit-
making system it had developed. The residents’ therapy 
included renovating cheaply bought real estate that 
could then be sold at a higher price. Some of the 
ex-residents who had remained in TC treatment for 
considerably long periods of time went on to become 
unpaid addiction therapists in the TC programmes, 
raising questions about the motives behind Engelmajer’s 
work. In 1995, the French commission of inquiry on 
sects (La Commission d’ enquête sur les sectes) 
unanimously classified ‘Le Patriarche’ as a sect 
(Prevensectes, 2012) and the interministerial delegation 
on the fight against addiction (MILDT: Mission 
Interministérielle de Lutte contre la Drogue et la 
Toxicomanie) stopped funding the organisation 
(Bourgeoin, 2006).
Current practice
In 1998, Engelmajer was forced to resign from his 
position by his own board of directors. Since then, 
‘L’Association Le Patriarche’ has changed direction and 
operates under a new name, Dianova, in the field of 
youth care and community-based social work. The 
organisation is represented in 11 countries across 
Europe and the Americas. Alongside Dianova, other TC 
programmes are ‘Le Bouriflet’, founded in 1978 by the 
association Sato Picardie, and ‘Le Mas Saint-Gilles’, 
established in 1994. The latter, with its aim of 
reintegration into society and education of residents, 
radically broke with the tradition of ‘Le Patriarche’ with 
its focus on stimulating dialogue and normal living 
situations.
Recent evolutions and future developments
The further development of TCs for the treatment of 
addiction in France was, to a large extent, a result of a 
governmental plan from 2004 to 2008 that encouraged 
and supported the establishment of TC programmes 
(Jourdan, 2007). To date, 11 TCs have been established 
and operate in France, looking after a total of 380 
residents. Two of these TC programmes were opened at 
the end of 2011.
In conclusion, French TCs for the treatment of addiction 
are currently undergoing considerable expansion. The 
MILDT not only subsidises these new initiatives but also 
takes care of the training and professional development 
of TC staff members, thus guaranteeing a professional 
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(Casselman, 1971). As a result, specialised treatment 
initiatives for illicit drug users were set up. These 
initiatives were often based more on an educational 
approach rather than a medical treatment model.
In 1972, the first residential treatment centre specialised 
in the treatment of persons with alcohol and drug 
problems was established in Belgium. Gradually, the 
treatment of young drug users in this clinic developed into 
a drug-free, concept-based TC, called De Kiem 
(Broekaert, 2006b). De Kiem was established under the 
impulse of Eric Broekaert (Ghent University, Department 
of Orthopedagogics), who had studied the Synanon 
movement in the USA. In 1974, the TC De Sleutel was 
founded by Johan Maertens. Both TCs were in close 
contact with the TCs Emiliehoeve and Essenlaan in the 
Netherlands and were therefore directly influenced by 
Phoenix House London and Phoenix House New York. 
More TCs followed (Broekaert et al., 2002). In 1978, TC 
Choisis, inspired by La Boère in France, was soon 
transformed into TC Ellipse, a psychoanalytical residential 
treatment programme for drug users. In 1979 and the 
1980s, TCs De Spiegel, Les Hautes Fagnes and Katarsis 
Trempoline followed. Finally, in the mid-1990s, two TCs 
were established with a strong focus on dual diagnosis. In 
1994, De Sleutel set up a second TC, specifically targeted 
at persons with a dual diagnosis, and in 1995 a TC for 
persons with drug problems, De Klimop (Rekem), was 
developed within a psychiatric hospital.
Current practice
In 2012, there were eight residential TCs for drug addicts 
in Belgium. Belgian TCs are drug-free treatment 
programmes predominantly oriented towards persons 
with illicit drug problems. This is explicitly stated in the 
contracts of the various TCs with the National Institute 
on Health and Disability Insurance (RIZIV/INAMI), which 
subsidises TCs in Belgium. Some of the TCs allow 
persons with alcohol problems by way of an exception. 
One of the eight TCs (TC Hautes Fagnes) has 
proportionally more persons with alcohol problems. Two 
TCs (TC De Sleutel for dual diagnosis and TC Klimop) are 
modified TCs targeted at persons with dual diagnosis.
Two Belgian TCs (De Kiem and Trempoline) have a 
so-called ‘reception centre’. This reception centre can be 
seen as a preparatory phase preceding admission to the 
TC. Other TCs have set up crisis intervention centres 
aimed at detoxification, motivation and orientation. 
When entering one of the Belgian TCs, persons have to 
be fully detoxified from methadone as well as any other 
substitution medication. Residents who have completed 
the TC programme can move on to a halfway house, 
speaking TC, and the Evada foundation began operating 
as a halfway house in Stockholm (Görransson, 1994). 
The four independent foundations collectively formed an 
umbrella organisation. In the mid-1980s, the 
organisation employed 250 staff members and provided 
treatment and care for 600 drug users.
Since the end of the 1980s, the Swedish TC network has 
been disrupted following reductions in funding. 
Commentators (e.g. Segreaus, 2011) have noted a 
number of factors implicated in the dismantling of the 
Swedish TCs, including but not limited to: (i) the financial 
crisis of the 1990s and the resulting scarcity of financial 
resources; (ii) the shift of political support to localising 
addiction treatment in the community as opposed to an 
isolated programme away from the drug users’ 
environment; (iii) the lack of evidence to support the 
effectiveness of the TC model; and (iv) the fact that the 
harsh encounter methods used in TCs were not 
compatible with the Swedish mentality.
Current practice
At present, there are almost 300 residential recovery 
centres in Sweden. Most of them offer 12-step 
programmes with durations of 29 days to 3 months. 
According to the official list of HVBs [Hem för Vård och 
Boende (Homes for Living and Treatment)], there are 
45–50 residential drug treatment programmes for adults 
in Sweden (Socialstyrelsen, 2012) and a number of 
residential treatment programmes for young people with 
drug-related problems.
I 2.2.4. TCs in Belgium
History
In the 1960s and 1970s, an increase in the use of 
various illicit substances such as marijuana and LSD 
(lysergic acid diethylamide) could be observed in 
Belgium. Use itself increased significantly, as did the 
number of associated problems. Most services that 
specialised in providing treatment to persons with 
alcohol or mental health problems were not keen to 
provide treatment to those persons with illicit drug 
problems (Vanderplasschen et al., 2002), predominantly 
because they believed that illicit drug users would not 
comply with the prevailing treatment regime. Also, the 
drug users themselves were not inclined to seek 
treatment in traditional mental health care settings, as 
they were afraid of facing judicial consequences 
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although this has not fundamentally changed the 
orientation and focus of the programmes. At present, 
treatment providers are more often confronted with 
treatment requests from older (heroin) users but have 
generally set a limit at the age of 40. Gradually, more 
attention has been given to the specific position of 
women in TCs. The majority of TC residents are male, but 
certain TCs organise specific women’s groups and each 
month a women’s day is organised by the BFTC on which 
female residents of the various TCs can meet and engage 
in specific activities. In most TCs, family workers are part 
of the TC staff. TCs have also increased the attention 
paid to the children of (future) residents. Some TCs run 
specific initiatives for mothers (and fathers) who want to 
enter the TC programme while staying together with their 
children. TCs have further become more aware of 
psychiatric comorbidity among residents and have 
gradually become more open towards the use of 
prescribed psychoactive medication in cases of severe 
mood, anxiety, personality or other psychiatric disorders. 
In some TCs, there is the possibility of detoxifying from 
methadone in the reception centre in order to lower the 
threshold for entering the TC.
TCs were the first specialised treatment initiatives for 
drug users in Belgium. Over the years, other types of 
treatment modalities and facilities specifically targeted 
at drug users have been established, such as daycare 
centres, detoxification programmes, social working 
places, prevention programmes, harm reduction 
initiatives and medical social reception centres providing 
methadone treatment. An important recent initiative was 
the creation of a drug-free wing (‘D-side’) in one of 
Belgium’s prisons, established with the help of TC staff 
members. Most of the TC founders played an important 
role in the development and establishment of a large 
part of these initiatives and are now engaged in a wide 
variety of treatment initiatives for both in- and 
outpatients (e.g. De Kiem, De Sleutel and Trempoline). 
Although Belgium now has a large variety of services 
involved in the treatment and support of drug users, the 
communication and cooperation between them has 
often been very limited (Vanderplasschen et al., 2002). 
Over the past decade an increase in (regional) 
collaboration efforts has been observed within the 
substance abuse treatment sector and also between 
this sector and other sectors (e.g. mental health care, 
judicial system), but large regional variations in levels 
and intensity of collaboration can be seen 
(Vanderplasschen et al., 2002).
In the (near) future, TCs, as well as other types of 
treatment modalities, will no longer be governed by the 
federal authorities, but by the regional and state 
authorities. At present, politicians and policymakers are 
which is aimed at facilitating reintegration into society. 
All Belgian TCs are members of the EFTC and are 
assumed to respect the ‘standards and goals for 
therapeutic communities’, which have been adopted 
unchanged from the WFTC.
Currently, the eight Belgian TCs have a total capacity of 
204 places (range: 15–35 places) and welcome on 
average 45 new clients each year (range: 20–95). Nearly 
all of the staff members are paid; few volunteers are 
involved on a day-to-day basis in Belgian TCs. Most of 
the staff members are professionals with either a 
bachelor’s degree in orthopedagogy, nursing or 
education or a master’s degree in psychology, 
orthopedagogics or criminology. In all TCs, general 
practitioners and psychiatrists are part of the 
multidisciplinary treatment staff. Proportionally, the 
number of staff members with a non-medical 
background is considerably greater than those with a 
medical background. Some of the TC staff members are 
ex-addicts, but they make up a small part of the total 
number of staff members working in TCs. Furthermore, 
these ex-addicts are encouraged to pursue a bachelor’s 
degree in social work or orthopedagogy in a part-time 
study programme while on the job.
In order to pass on the knowledge, skills and attitudes 
associated with working in a TC environment, most of 
the Belgian TCs hold on to a ‘resident internship’ for all 
new staff members. This ‘resident internship’ allows new 
staff members to get to know the TC principles and 
methods from the inside out by becoming a resident for 
a period of time in one of the other Belgian TCs. 
Furthermore, the TCs also provide internal training 
opportunities for both new and more experienced staff 
members and they are united in the Belgian Federation 
of Therapeutic Communities (BFTC), which organises 
annual workshops for all its members on a topic of 
interest. Finally, staff members of TCs participate in 
generic training programmes organised by umbrella 
organisations or training centres.
Recent evolutions and future challenges
Over the years, Belgian TCs have evolved in certain areas: 
a shift in the primary drugs that residents use upon 
admission; more attention to women; greater involvement 
of the family and the broader social network of residents; 
more attention paid to psychiatric comorbidity; and a 
closer collaboration among substance abuse treatment 
providers and with other sectors. In TCs, a shift has been 
observed in the primary substance that people misuse 
upon admission (increase in the use of cocaine and 
amphetamines; stabilisation of heroin problems), 
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As in other European countries, the TCs along the lines 
of ‘Le Patriarche’ have evolved rather isolated from the 
mainstream TC movement, as they are often closed 
communities and can include unsavoury businesses 
under threat of becoming a cult (Broekaert et al., 2006). 
Therefore, ‘Le Patriarche’ started a process of internal 
restructuring and changed its name to Dianova. More 
democratic principles were adopted and services 
professionalised (Comas Arnau, 2006). Although TC 
networks run by Dianova and Proyecto Hombre are 
partially supported by private resources, there are also 
several public and private, non-governmental (publicly 
funded) TCs in Spain.
Current practice
A review of recent national reports on the drug situation 
in Spain shows that the number of TCs and TC residents 
has remained rather stable, but these services are not 
spread equally across the country. According to the 
latest report of the National Plan on Drugs (Plan 
Nacional sobre Drogas, 2009), the number of TCs was 
129 in 2009, 68 of which were managed by non-
governmental organisations. The total number of 
residents in 2009 was 8 134. Proyecto Hombre is one of 
the largest organisations providing TC treatment in 
Spain and consists of 32 TCs all over Spain, including 
conventional TCs, modified TCs for dual diagnosis, three 
TCs in prison (Orense, Córdoba and Madrid/Soto del 
Real) and some urban TCs (Valladolid, Burgos, Almería).
According to the 2011 national report, Spain has an 
extensive network of (outpatient) resources for treating 
drug-related problems, including risk and harm reduction 
programmes, crisis and detoxification centres, training 
workshops and substitution treatment. TCs have been, 
and continue to be, a key link in this chain of services 
and have progressively adapted to changes in the 
population for which they provide care. TCs have evolved 
from rather isolated programmes into specialised 
residential environments that are part of a 
comprehensive network of support services for drug 
addicts. A TC programme is specifically recommended 
for drug users with serious personality disorders, limited 
family support and multiple previous treatment failures.
Spain’s TCs are structured educational environments in 
which drug users live together to achieve social 
reintegration without drugs (Comas Arnau, 2010). They 
integrate various psychological theories (i.e. behavioural, 
humanistic and psychodynamic) and therapeutic 
approaches and can be regarded as places for social 
learning (García Llaneza, 2010). The treatment 
programmes typically consist of three phases: ‘acogida’ 
preparing this important shift, but little information is 
currently available. However, this will certainly imply 
administrative and financial consequences. In times of 
scarce financial resources, it can also be expected that 
all treatment providers will have to be able to 
demonstrate some proof of effectiveness in order to 
justify the investment of public resources.
I 2.2.5. TCs in Spain
History
In response to the emerging heroin epidemic in the 
mid-1970s, the first TCs for drug addicts were 
established in Spain in 1979 (Comas Arnau, 1988). 
These TCs were inspired by ‘Le Patriarche’ communities 
in France and were run by ex-addicts, without public 
financial resources. By 1983, there were about 13 
drug-free self-help TCs in Spain that had been created 
with the help of private and public institutions (Broekaert 
et al., 2006). In 1984, Proyecto Hombre — modelled 
after the Italian Projecto Uomo, where the first Spanish 
professionals (Juan Francisco Orsi and Aitor Aresti) were 
trained — founded its first TC. Owing to the increasing 
number of drug problems in the 1980s, Proyecto 
Hombre (1) opened TCs all over Spain during that period.
From the 1990s onwards, the harsh TC treatment 
methods of the early days were replaced with more 
dialogue and open communication, and democratic TC 
principles (see Bridger, 1990) were introduced in 
concept TCs. Given the strong connection with CeIS 
(Centro Italiano di Solidarietà) in Italy, a cross-
fertilisation of drug-free and democratic TC traditions 
has characterised the development of TCs in Spain from 
the beginning. Since the official introduction of 
methadone maintenance treatment (MMT) in 1996, the 
number of centres offering MMT and the number of 
users of this service grew constantly, while the number 
of cases treated in detoxification hospitals and TCs 
dropped (EMCDDA country report, 2000). More recently, 
TCs have been adapted to serve the special needs of 
various groups of drug addicts such as adolescents, 
persons with dual diagnosis and mothers with young 
children. Such modified TCs have been established in 
psychiatric hospitals, prisons and methadone 
maintenance services.
(1)  Proyecto Hombre should not be regarded as a treatment method, but 
rather as a philosophy with a focus on humans and their development. 
At the moment, Proyecto Hombre is one of the largest treatment 
networks for drug addicts in Spain, including various types of 
abstinence-oriented treatment modalities (e.g. TCs).
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are requested to pay for their treatment according to 
their ability.
Recent evolutions and future challenges
One of the recent evolutions in TC treatment in Spain is 
the establishment of prison TCs. In 1998, the first TC in 
prison was started in Madrid (Soto del Real prison), 
followed by a second case in Ourense in 2001 (Pereiro de 
Aguiar prison). In addition to these penitentiary TCs, 
so-called ‘therapeutic modules’ have been introduced to 
motivate drug users to continue treatment after their 
prison sentence. Furthermore, the number of drug-using 
prisoners diverted from prison to community TC 
treatment each year is slightly increasing. The growing 
interest of the judicial authorities in TC treatment is not 
reflected in the policy of the Ministry of Health, and 
several community TCs have been closed in recent years.
Given the economic recession in Spain and the rest of 
Europe, governments may further save on long-term 
substance abuse treatment, which will particularly 
endanger publicly funded programmes (Regal Ledo, 
2010). Moreover, financial cutbacks can affect the 
integrity of the TC model (e.g. number of staff, duration 
of treatment). Therefore, continual training in the TC 
method is necessary to safeguard this unique approach. 
Recently, more severe neurological damage and a more 
severely deteriorated physical condition have been 
observed in drug users entering TC treatment, which 
brings about new challenges.
Furthermore, the high unemployment rates in Spain 
hamper the reintegration of drug users into society, as 
relapse is more likely without having a structured day 
provided by work. As a consequence of the reduced 
financial resources, drug addicts are more frequently 
referred to evangelical/religious communities by 
professional services (Comas Arnau, 2006). Residence 
in these communities is usually free of charge, but they 
are not controlled or accredited by a governmental 
authority. Such religious communities should not be 
regarded as concept TCs, as the focus in these 
communities is on physical work and praying.
I 2.2.6. TCs in Poland
History
In the late 1970s, the number of people addicted to 
kompot, or ‘Polish heroin’, spread rapidly, but the regime 
(outpatient motivational, preparatory programme), TC 
treatment and the re-entry phase (preparation for social 
reintegration, including job counselling and individual 
action plans). Treatment duration varies from TC to TC 
and from case to case, but in general the ‘acogida’ phase 
lasts 6–9 months, followed by an inpatient stay of 9–12 
months. Not all TC programmes are preceded by an 
outpatient motivational phase, but the re-entry 
programme is strongly recommended after TC 
treatment. The TC phase is in principle residential, but 
where there is sufficient family support it can be 
replaced by day treatment programmes, based on TC 
principles. As methadone is the standard treatment for 
heroin users in Spain, most TC programmes admit 
persons on methadone, although the ultimate treatment 
objective is abstinence.
The number of professionals working in TCs in Spain is 
around 1 500. Most TCs (in particular the Dianova and 
Proyecto Hombre TC programes) employ recovered 
ex-addicts, who make up 20–30 % of all staff in Proyecto 
Hombre. Other, qualified professionals in TCs are, among 
others, psychologists, educators, pedagogues, social 
workers, nurses and medical doctors. A division between 
so-called ‘professional’ and ‘non-professional’ TCs (that 
employ ex-addicts) has been observed. Around 60 % of 
all TCs in Spain also employ volunteers, some of whom 
are relatives of drug addicts and who fill administrative, 
domestic or treatment-related functions (Comas Arnau, 
2006). The involvement of volunteers is regarded as 
being of vital importance for promoting the social 
inclusion of drug users.
Continuing professional training and development 
ensures the quality of drug treatment provision in TCs in 
Spain. Since 1990, Proyecto Hombre has used a training 
institute in Madrid for the training of all staff members 
into the TC method, based on a published set of 
guidelines for the provision of TC treatment (Yubero et 
al., 2007a, b).
Three out of four TCs in Spain are run by private 
organisations, whereas the remainder depend on public 
authorities such as autonomous communities, provinces 
and cities (Comas Arnau, 2006). TCs can be accredited 
by state, provincial or local authorities. Quality control is 
limited to sanitary and safety inspections and 
regulations regarding the number and categories of 
professional staff.
Although public TCs receive funding from the Ministry of 
Health, some non-governmental organisations (e.g. 
Dianova, Proyecto Hombre) use additional private funds. 
Consequently, treatment fees may differ substantially 
between TCs; for example, in Proyecto Hombre residents 
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Currently, the treatment system for drug addicts 
includes 85 TCs (2 852 beds), which, within a given year, 
serves over 10 000 residents in total (National Bureau 
for Drug Prevention, 2011). The majority of the TC 
programmes are run by non-governmental organisations, 
funded by the National Bureau for Prevention of Drug 
Abuse. The National Bureau sets the quality standards 
for TC treatment provision, to which TCs are requested 
to adhere (Moskalewicz, 2009). In addition to standard 
adherence, all publicly funded TCs are expected to meet 
legally defined criteria regarding staff, types of service 
provision and professional and ethical standards 
(Koczurowska, 2006).
TC programmes today are adapted to clients of different 
ages and specific needs. There are programmes for 
children and adolescents up to 19 years old, for adults 
aged 19–25 years and for adults over 25 years old. These 
programmes differ in the recommended duration of 
residential treatment: the short-term (3–6 months) and 
medium-term (6–12 months) programmes focus on 
young people and persons with less severe drug 
problems, while the long-term (12–18 months) 
programmes look after adults with a long-standing or 
more severe drug-related problem. In accordance with 
the TC model, all clients go through an adaptation stage 
(typically in an outpatient setting), a residential stage 
and a re-entry (aftercare) stage. Clients are referred to 
TCs by specialised counselling units, family doctors or 
courts (Koczurowska, 2006). Upon entry to the TC, 
clients have typically undergone detoxification and are 
free from drug use including methadone and other 
substitution medications.
Recent evolutions and future challenges
One of the recent evolutions in TC treatment in Poland is 
the establishment of prison TCs (Moskalewicz, 2009). By 
2009, 16 medium-term (six months) drug-free treatment 
programmes had been implemented in specific 
therapeutic wards of correctional institutes. These 
programmes were based on specific TC elements, 
ingredients of the Minnesota model, social learning and 
cognitive–behavioural interventions. According to 
Charmast Masza (personal communication, 5 June 
2012), no current evaluation research exists on TC 
treatment. However, the Polish Federation of Therapeutic 
Communities is preparing an in-depth assessment of 
Polish TCs.
of that time denied the existence of drug addiction in the 
socialist society, so no specialised drug treatment 
services existed. Drug treatment, including 
detoxification and psychotherapy, was provided in 
psychiatric hospitals. It was in such circumstances that 
Marek Kotański, a charismatic psychologist, established 
the first TC for drug addicts, called MONAR. This TC was 
modelled on the US TC Synanon. MONAR became 
officially registered as a legal entity and non-profit 
association in 1981 and has since established five TC 
programmes in different regions of Poland.
During the late 1980s, when Poland was confronted with 
the AIDS epidemic, MONAR became an asylum for 
HIV-infected drug addicts. During this period, the 
association established a special TC house for women 
and children with HIV (Koczurowska, 2006). In the 
1990s, after the end of the communist regime, MONAR 
opened other services that were modified to fit the 
needs of socially disadvantaged groups including 
homeless and unemployed drug users, juvenile 
delinquents and ex-prisoners.
Other organisations that began delivering TC treatment for 
addicts, based on the MONAR experience, included the 
non-governmental organisation KARAN (initiated by the 
Catholic Anti-Drug Movement), which opened a TC for 
adolescent addicts; the Society for Drug Prevention, which 
established another TC for adolescents; the Catholic 
Centre for Upbringing and Resocialization for Youth; and 
TC ‘Familia’, established especially for the treatment of 
dually diagnosed clients (Koczurowska, 2006).
Current practice
A review of the EMCDDA country reports (2000–09) 
showed that while other forms of treatment, such as 
harm reduction and substitution treatment, found their 
way in the Polish treatment system in the early 1990s, 
drug-free TCs have been considered to be among the 
more widely accepted types of treatment. In contrast to 
most other European countries, the Polish substance 
abuse treatment system invested most of its resources in 
residential treatment services as opposed to ambulatory 
or outpatient treatment services. Generally, drug 
addiction treatment is provided by non-governmental 
organisations, public health institutions and private 
organisations. Treatment in these facilities is free of 
charge, except for the private drug clinics and private 
practices. The main types of substance abuse treatment 
services are inpatient and outpatient centres, 
detoxification wards (mainly established in hospitals), 
drug wards in prison and post-rehabilitation programmes. 
Drug-free TCs are part of the inpatient services.
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therapeutic programme consists of group and individual 
therapy, in combination with work (e.g. household, 
kitchen, garden) and educational activities. The 
treatment duration varies between 10 and 12 months. 
The residential TC programme is usually preceded by 
compulsory detoxification, which is provided in 
psychiatric hospitals (Adameček, 2007). Residents are 
prepared for reintegration into the community during the 
last phase of treatment and this is sometimes followed 
by continuing care. Methadone and other substitution 
medicines are typically not used in most TCs, although 
this policy is applied in a more flexible way in cases of 
dual diagnosis (Sobotka, 2007).
TCs are regarded as high threshold services for drug 
users interested in maintaining abstinence (Radimecký, 
2007). In the absence of large-scale substitution 
programmes, as a result of the relatively low prevalence 
of heroin dependence in the Czech Republic (EMCDDA, 
2012), TCs play an important role in the Czech drug 
treatment system and are allocated 9.2 % of the total 
drug policy budget (EUR 2 302 000) (MravČik et al., 
2011). However, the continuity of these services is not 
warranted, since TCs are subsidised on a year-to-year 
basis. Moreover, TCs are allowed to receive only up to 
70 % of their budget from the state. Additional resources 
are generated from other sources, including fundraising 
activities, private donations and project grants.
TC residents in the Czech Republic are mainly 
methamphetamine users (71.6 %), while only 16.7 % 
report heroin as their primary drug (MravČik et al., 2011). 
The majority of residents are injecting drug users 
(85.8 %). About 35 % of the residents have a dual 
diagnosis (Kalina, 2007), while adolescents and 
addicted women are other special needs groups that can 
be treated in some TCs but for whom some special TCs 
have been created. The average treatment duration is 
185 days. Only 28.9 % complete treatment successfully 
and 44 % of all early dropouts leave the TC within 3 
months. Several TCs welcome special target groups (e.g. 
adolescents, mothers with children, dually diagnosed 
individuals) and some have been dedicated to these 
populations.
TCs are run by multidisciplinary teams, including 
medical, psychological, social and pedagogical 
professions. A long tradition of specialised training and 
education is observed: addiction treatment has been 
incorporated as a specialisation in medical doctors’ 
education since 1980, and since 2005 bachelors and 
masters in addictology (Faculty of Medicine, Charles 
University, Prague) can graduate as specialists for 
supporting and treating drug addicts. In addition to 
education and professional background, personal 
I 2.2.7. TCs in the Czech Republic
History
Before the Velvet Revolution (1989), illicit drug use in 
former Czechoslovakia was limited, because of the 
strong social control and closed borders, and mainly 
concerned home-made products such as marijuana, 
hydrocodone and methamphetamine (pervitin). 
Following the splitting of Czechoslovakia in 1993 into 
the Czech and Slovak Republics, a drug epidemic was 
observed in the Czech Republic as a result of political 
and economic reforms, changing values and lifestyles, 
weakened outer border and social controls, and, 
because drugs were a taboo, the absence of drug 
prevention and legislation.
Long before the late arrival of illicit drug problems in the 
Czech Republic, the first TC-based hospital ward for 
alcoholics was established in 1948 by Jaroslav Skála in 
Prague (Apolinář). Later, similar (democratic) TCs were 
opened for persons with neuroses, psychoses and 
personality disorders, with an emphasis on heavy 
physical and mental work and taking responsibility for 
one’s own life. Since this approach appeared to be 
unsuitable for young drug addicts with immature 
personalities, specific TCs for this population were 
established from the 1990s. Czech drug-free TCs 
developed quite independently from TCs for addictions in 
the rest of Europe, and are clearly indebted to the long 
national TC tradition (Bém et al., 2003). An important 
influence in this TC movement is the role of SUR, a 
psychotherapy training centre named after its founders, 
Skála, Urban and Rubeš, who were involved in the 
development of the first TCs in the Czech Republic. Until 
now, most TC professionals have followed psychotherapy 
training in SUR, explaining the strong psychodynamic 
and group dynamic orientation in Czech TCs.
Current practice
In 2010, 10 TCs for the treatment of addictions were 
subsidised by the Czech Government Council for Drug 
Policy Coordination (GCDPC). The overall capacity of 
these TCs was 160 beds, and a total of 408 clients were 
treated in these programmes in 2010 (MravČik et al., 
2011). The exact number of TCs is difficult to determine, 
as two TCs are certified by the Czech Association of 
Non-governmental Organisations for Drug Addicts but 
not by the GCDPC.
Czech TCs are usually small (15–20 residents) and their 
functioning resembles a family hierarchy. The 
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I  2.3. Summary of developments in European therapeutic communities
This chapter has shown how the so-called hierarchical 
concept TC originated in the late 1950s in the USA as an 
offspring of AA. The TC was introduced in Europe at the 
end of the 1960s and 1970s in the United Kingdom and 
was often used as an alternative for psychiatric 
treatment. It matured during the 1980s and spread all 
over Europe. Throughout the 1990s, its rise was 
interrupted because of problems with charismatic 
leadership in some TCs, a lack of evidence of their 
effectiveness from RCTs and a general tendency in 
society to cut down on residential care. The rollout of 
opioid substitution treatment (OST) a means of fighting 
the HIV epidemic in many cases was accompanied by a 
reduction in treated cases and treatment facilities in TCs.
Europe learnt much from the USA when setting up TCs. 
Synanon, Daytop and Phoenix House were either copied 
or adapted to national situations. During the early history 
of TCs, the US TC programmes were mostly built on 
strong self-help principles, including identification with 
older ex-addicts, whereas the TC movement in Europe 
from the beginning was set up by professionals with 
backgrounds in psychology, education or pedagogy. 
However, there were also national experiences and 
traditions that influenced developments. In the Czech 
Republic, for example, old TC traditions in alcohol 
treatment were the main source of national 
developments. In several countries, TCs set up by 
charismatic leaders developed into sect-like 
organisations, which led to legal steps being taken and a 
loss of public funding. TCs have historically been 
vulnerable to charismatic leadership, as illustrated in 
Spain, France and Sweden — this leadership can attract 
a number of drug users and resources for the TC 
programme, while at the same time exposing the 
programme to the risk of isolation and secrecy. Possible 
ways to prevent the exposure of TCs to charismatic 
leadership would be by arranging the financing of TC 
programmes by public authorities rather than by private 
resources, alongside the enforcement of quality control 
in TCs by external bodies.
As the concept of a standard TC matured, it was 
modified to address the needs of special populations. 
For instance, confrontations in encounter groups are not 
appropriate for psychotic residents and dually diagnosed 
individuals (Sacks et al., 2012), and modified TC 
approaches were developed for these populations in 
Belgium, the Czech Republic, Spain and Poland. The 
observation that not many women graduated from TCs 
led to the introduction of programmes for addicted 
experience and skills are also deemed important in TCs. 
Consequently, recovered ex-addicts are sometimes part 
of the staff, but it is rather unusual to have volunteers in 
the therapeutic team. Lifelong learning (e.g. participation 
in certified courses, internships in certified facilities, 
SUR psychotherapy training, regular supervision, 
conferences) is compulsory for any professional working 
in addiction treatment and should guarantee the quality 
of care.
TCs need to meet the quality standards of regular social 
services as they are controlled and subsidised by the 
Ministry of Labour and Social Affairs. As these 
standards are not specific to drug addiction services, 
the GCDPC has implemented its own certification 
standards for a range of addiction services (including 
TCs). The certification process includes general and 
specific standards for each type of drug service and 
consists of staff ethics, clients’ rights and aims and 
guidelines for TCs and other services (see Chapter 4) 
(Adameček, 2007). These standards should not be 
regarded as evidence-based guidelines but are based 
on expert opinions. The ethical code approved by Czech 
TCs is based on the ethics code of the WFTC (MravČik 
et al., 2011).
Recent evolutions and future challenges
Recent trends and challenges regarding treatment in 
TCs include the differentiation towards special needs 
groups (e.g. dually diagnosed individuals, drug users 
coming from prison) and also changes in substance use 
patterns (e.g. illegal buprenorphine is now the main 
type of opioid dependence). Adequate psychiatric care 
and more individualised approaches have been 
introduced in TCs to meet these emerging needs. 
Second, the TC capacity is not in line with the demand 
for treatment, resulting in waiting lists in every TC and a 
great number of drug addicts being treated in 
non-certified TCs. Third, economic cutbacks have 
resulted in a reduction in the number of staff in TCs. 
As a consequence, staff working night shifts have been 
replaced with telephone availability during the night. 
Furthermore, TCs try to make extra money from farming 
and selling products and also by producing their own 
food (e.g. meat, eggs and vegetables). Finally, outreach 
activities are needed to reach drug addicts in prisons, 
as there is no treatment available in these settings 
(except counselling and motivational interventions), or 
Roma people, as they often have no contact with 
regular treatment services.
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mothers and children whereby mothers follow TC 
treatment during the day and spend the rest of the time 
with their child(ren) in a TC annex (e.g. TC De Kiem in 
Belgium). Prison TCs began to be implemented in 
Europe (e.g. in the United Kingdom) and could present a 
notable niche for future modified TCs in other countries. 
Similar approaches to modified TCs are also available for 
homeless and adolescent substance abusers (De Leon, 
1997).
For many years, the TC movement has been considered 
to be opposed to psychiatric or methadone maintenance 
services. Recently, TCs have involved themselves in 
integrative treatment systems (Broekaert and 
Vanderplasschen, 2003). This implies a focus on 
coordination and continuity of care to improve 
effectiveness and efficiency. It involves taking on board 
alternative approaches from outside the TC movement, 
in accordance with the needs of residents and their 
specific diagnoses. TCs work closely with the mental 
health care system; sometimes TCs even share premises 
with other therapeutic departments.

3
41
be more effective than democratic TCs, although this 
finding may have been moderated by the fact that 
studies of democratic TCs were generally much older 
(15 years or more) and addressed more severely 
disordered persons.
The often-cited Cochrane review by Smith, Gates and 
Foxcroft (2006) focused exclusively on concept, 
drug-free TCs for the treatment of addictions, based on 
the results of seven RCTs. TC treatment was compared 
with various types of control conditions, including day 
treatment, community residence and TCs with short or 
long programmes. The outcomes studied included 
treatment completion, changes in substance use, and, if 
reported in the original papers, other outcomes (e.g. 
employment, criminal involvement). The authors 
concluded that there was little evidence that TCs could 
offer significant benefits in comparison with other types 
of residential treatment, or that one type of TC was 
better than another in terms of drug use-related 
outcomes and retention in treatment. The review and 
meta-analyses, however, are based on a limited number 
of studies, some of which have notable methodological 
limitations. For example, the randomisation process in a 
number of included trials was characterised by 
substantial attrition, and treatment dropout was also 
often observed. Consequently, Smith and colleagues 
(2006) have recommended setting up more clinical 
trials, as well as using pragmatic study designs that 
retain all subjects in the analyses in order to better 
document the effectiveness of TCs.
De Leon (2010) has challenged the assertion that, 
because of the insufficient RCT-based research on the 
effectiveness of TCs, the effectiveness of this treatment 
modality has not been ‘proven’, and conducted a non-
exhaustive, but comprehensive, review of the North 
American literature on TCs, sourcing evidence from the 
following: (1) field effectiveness (observational) studies 
employing a longitudinal, naturalistic design that follow 
TC residents during and after treatment — some of these 
studies were large-scale studies, evaluating the 
effectiveness of a range of treatment modalities, including 
TCs [e.g. Treatment Outcome Prospective Study (TOPS), 
This chapter provides an overview of the evidence on the 
effectiveness of TCs detailed in the published 
international literature. The first part (section 3.1) 
summarises the main findings from systematic reviews 
conducted to date; the following sections provide a new 
systematic review and the results of TC outcome 
research focused on (i) international randomised and 
non-randomised controlled studies and (ii) European 
observational research.
I  3.1. Findings from available reviews
Over the last decade, four independent reviews (Lees et 
al., 2004; Smith et al., 2006; De Leon, 2010; Malivert et 
al., 2012) have been published in the English-language 
literature on the effectiveness of drug-free TCs. The 
conclusions from these reviews are quite divergent, 
which can be partly explained by the different scope, 
objectives, selection criteria and analytical methods 
applied in these studies. Few publications were included 
in all four reviews. For this reason it was found useful for 
this publication to review all existing TC studies meeting 
the inclusion criteria and which follow the definition 
provided in section 1.2.
The first systematic review and meta-analysis on the 
effectiveness of TCs was conducted by Lees, Manning 
and Rawlings (2004) in the United Kingdom, and was 
based on 29 (21 non-randomised and eight randomised 
controlled trials). Given the long tradition in the United 
Kingdom of democratic TCs for individuals with 
personality disorders, the authors did not restrict their 
search criteria to ‘concept’ TCs, resulting in the inclusion 
of studies with a substantially heterogeneous 
population. Overall, this meta-analysis demonstrated a 
strong positive effect of TC treatment compared with a 
range of control interventions [summary log odds 
ratio = –0.512 (95 % CI –0.598 to –0.426] (Lees et al., 
2004). This global outcome measure was a summary 
score, based on various criteria. If available, a 
conservative indicator (e.g. reconviction rate) was used. 
Concept TCs for the treatment of addictions appeared to 
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substance use outcomes were difficult to compare 
across studies. Methodological limitations in the original 
studies did not allow differentiation between persons 
who relapsed to their primary problem substance and 
those with a new addiction, or between persons who 
used occasionally or moderately and heavy users, thus 
preventing this review from reaching a conclusion on the 
long-term benefits of TC treatment. TC treatment 
completion and retention in treatment were identified as 
the most robust predictors of abstinence at follow-up 
(Malivert et al., 2012).
To date, research endeavour has consistently been 
devoted to establishing the effectiveness of TCs as a 
treatment for addictions. However, the available evidence 
base has yet to be strengthened, by properly designed 
and conducted controlled research. Two meta-analyses 
demonstrated that, although TCs for addictions can be 
considered to be more effective than TCs for personality 
disorders (Lees et al., 2004), the evidence base is limited 
for the effectiveness of TCs compared with other forms of 
residential treatment (Smith et al., 2006). Malivert and 
colleagues (2012) observed considerable reductions in 
substance use during and after TC treatment but also 
substantial relapse rates (around 50 %) over extended 
follow-up periods. The only finding that all four reviews 
confirm is that length of stay in treatment is associated 
with better outcomes in terms of drug use and recidivism, 
and the longer that residents are retained in TC treatment, 
the more enduring the observed abstinence following TC 
treatment (Malivert et al., 2012).
In Europe to date, no controlled studies of drug-free TCs 
have been conducted, and findings from observational 
studies have not been systematically reviewed. The RCT 
design is considered the ‘gold standard’ for the 
generation of scientific level 1 evidence about the 
efficacy of treatments (Glasziou et al., 2007). However, 
applying RCT or quasi-experimental research designs 
(e.g. interrupted time series study, historically controlled 
study) appears to be problematic for the evaluation of 
complex and integrated interventions such as the TC 
(Gossop, 2012). Observational studies can be 
particularly helpful for treatment evaluation in 
naturalistic settings, where ethical, pragmatic or 
scientific considerations may prevent researchers from 
setting up controlled studies.
I 3.2. The present review
This review builds on earlier reviews of the literature by 
bringing into focus and systematically reviewing 
international randomised and non-randomised 
Drug Abuse Treatment Outcome Studies, (DATOS)] , while 
others were ‘case’ studies exploring the effectiveness of a 
single TC programme (e.g. Phoenix House); (2) controlled 
studies of TCs or modified TCs, evaluating treatment 
effectiveness in comparative terms, relative to another 
treatment condition or no treatment in the context of a 
controlled (non-)randomised experiment; (3) meta-
analyses using statistical techniques to assess the 
effectiveness of TCs relative to a comparison (no) 
treatment condition, based on combining results from 
different studies; and (4) economic analyses looking at the 
cost and economic evaluation of TCs.
The evidence from these sources was in support of the 
effectiveness of TCs. Multiple field effectiveness studies 
have demonstrated the relationship between retention in 
TC treatment and positive treatment outcome. An 
analysis of eight controlled studies, of which seven were 
RCTs, demonstrated that TC treatment outcome was 
significantly better in terms of drug use, legal 
involvement and employment outcomes than a non-TC 
control condition. Five published economic (cost–
benefit) evaluations have demonstrated high TC 
treatment delivery costs, which were, however, 
compensated for by the significant savings to society 
— in particular, the reduction in the costs of criminal 
proceedings as a result of associated criminal activity 
and gains from participants being restored to 
employment. De Leon (2010) concludes that there is 
substantial evidence in support of TC treatment. He 
refers to the strength of the relation between treatment 
completion and positive outcome, treatment dosage and 
post-treatment success and the differential 
effectiveness of TCs compared with other treatment 
modalities (especially for clients with severe problems). 
Treatment outcomes might also be affected by self-
selection (i.e. motivation for treatment) and self-
matching (i.e. clients’ choice for a specific treatment) 
processes (De Leon, 2010).
Most recently, Malivert et al. (2012) conducted a 
systematic review — comprising 12 studies — with a 
focus on TC treatment process and outcome. Studies of 
prison TCs were excluded from this review. Reported 
treatment completion rates varied widely across the 
studies (from 9 % to 56 %), with programme cessation 
occurring most often during the first 15–30 days of 
treatment. All reviewed studies showed a decrease in 
substance use during the follow-up periods, although 
between 21 % and 100 % of the study subjects had used 
substances or met criteria for relapse during the 
follow-up periods. Between 20 % and 33 % of the study 
populations re-entered treatment during the studies’ 
follow-up periods. Given the large differences in 
treatment duration and length of follow-up period, 
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ongoing studies on the effectiveness of addiction TCs. 
Those contacts yielded two additional studies: one from 
the Czech Republic and one from Poland. At the time of 
writing, the latter study is at the conceptualisation stage. 
Preliminary and unpublished data, which will be 
presented separately in this review, are available for the 
Czech study (Šefránek, 2012).
I Inclusion and exclusion criteria
Eligible studies reported:
Intervention: drug-free TC for the treatment of addiction 
(also referred to as ‘concept TCs’, see Chapter 1 for 
definition).
Target population: drug- (and alcohol-) dependent users 
— studies including persons with co-morbid psychiatric 
disorders were eligible for inclusion if all study 
participants had a drug addiction.
At least one of the following outcomes was reported: 
retention in treatment; treatment completion; dropout; 
substance use; employment status; criminal 
involvement; health and well-being; family relations; 
quality of life; mortality.
Type of studies:
n  Controlled studies: RCT and non-randomised 
(quasi-experimental) studies (QES) that have 
evaluated post-treatment TC outcomes relative to a 
control condition; no country restriction was applied 
for selecting these types of studies.
n  Observational studies: single- or multi-programme 
studies that have examined post-treatment TC 
outcomes; studies were restricted to those 
conducted in countries of the EU plus Norway, Turkey 
and Switzerland.
Non-English-language publications were considered for 
inclusion. Available systematic reviews and meta-
analyses were not included, but all studies selected for 
these reviews were screened based on the 
aforementioned inclusion criteria. Studies were excluded 
if they did not distinguish TC treatment from other 
residential treatments for addiction.
I Study selection and data extraction
The abstracts retrieved in the literature searches described 
above were screened by two reviewers for potential 
relevance; full text papers for the selected abstracts were 
controlled studies (referred to as ‘controlled’ research 
henceforth in this publication) and European studies 
using observational designs to evaluate the effectiveness 
of TCs. Although a number of observational studies have 
been set up in North America and other parts of the 
world, for pragmatic reasons this  study includes only 
observational research in the EU and Turkey, Norway and 
Switzerland.
I Study identification
The following databases were searched for eligible 
records published up to 31 December 2011: ISI Web of 
Science (WoS), PubMed and DrugScope. There were no 
language restrictions (2). Search strategies were 
developed for each database, based on the search 
strategy developed for ISI Web of Knowledge, but revised 
accordingly to take into account differences in vocabulary 
and syntax rules. The following terms or combinations of 
these terms were used in the search strategy: ‘therapeutic 
communit*’ AND ‘drug* or addict* or dependen* or 
substance use’ AND ‘outcome* or evaluation or follow-up 
or effectiveness’. In addition, the reference lists of 
retrieved studies and of available reviews were checked 
for relevant studies, as well as screening the index of the 
International Journal of Therapeutic Communities, a 
specialised peer-reviewed journal on TCs.
In addition to the database search, abstracts of 
conferences of the EFTC, the WFTC and the European 
Working Group on Drugs Oriented Research (EWODOR) 
and grey literature were scanned for relevant 
(un)published studies, and metaRegister of Controlled 
Trials, Clinical Trials and Trials Central registers were 
searched to ensure that no ongoing trials were 
neglected. One RCT that is under way was identified 
[Oxfordshire Complex Needs Service (OCNS, Oxford, 
UK)], but as it concerned a day treatment TC facility for 
persons with personality disorders (not in combination 
with a drug addiction) this study was not included. 
Where publications, particularly older ones, could not be 
tracked through the Ghent University online library 
system, the study authors were contacted and asked to 
provide a copy of their manuscript.
Finally, TC experts in various countries, including George 
De Leon (USA), Rowdy Yates (United Kingdom), Edle 
Ravndal (Norway), Albert Sabates (Spain), Kamil Kalina 
(Czech Republic), Andrea Ascari (Italy) and Masza 
Charmast (Poland), and the EMCDDA’s network of NFPs 
were contacted to identify additional (un)published or 
(2)  The search strings were in English only; national experts and authors 
were contacted for access to non-English-language publications.
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the effectiveness of TCs with that of other treatment 
modalities/conditions studied (based on controlled 
research) on a range of outcomes (as detailed above) 
and focuses on the effectiveness of TC treatment with 
regard to a range of outcomes (based on controlled and 
observational research).
I Results
A total of 185 abstracts and 73 full text papers were 
reviewed, yielding 49 papers, of which 28 report controlled 
studies and 21 report observational studies on the 
effectiveness of TC treatment for addiction (Figure 3.1).
I 3.2.1 Controlled studies
A total of 45 potentially eligible papers reporting 
controlled studies were identified from the multiple 
sources described above. After reading the full texts of 
45 articles, 28 met the inclusion criteria and were 
retained in this review. Table 3.1 provides a list of the 
included papers, as well as indicating which of these 
publications were included in previous reviews (n = 14) 
and which were not (n = 14). Recent studies (published 
since 2001) have not been included in any of the 
aforementioned reviews (see section 3.1). Consequently, 
more than a quarter of all controlled studies were not 
analysed in any of the reviews conducted to date.
obtained and further screened by at least two reviewers. 
The following information was extracted, where available, 
from each paper and presented in Table 3.1 (controlled 
studies) and Table 3.4 (observational studies):
n  study features: author(s), year of publication; 
geographical area (country/state/region); recruitment 
site(s); study design; time to follow-up; in addition, for 
cohort studies, information on numbers/proportion of 
participants followed up and lost to follow-up was 
collected;
n  sample characteristics: sample size; problem drug/
alcohol use; inclusion criteria;
n  treatment characteristics: type of treatment studied; 
treatment setting; duration of planned treatment 
programme;
n  outcomes studied and study findings: retention in 
treatment, completion of planned treatment 
programme, dropout rate; substance use (illicit drugs 
and alcohol); criminal involvement; employment; 
other outcomes (e.g. physical/mental health, housing, 
quality of life).
The results of the review are presented in two parts, 
each describing the findings of (1) controlled studies 
irrespective of the country in which they were conducted 
and (2) observational studies conducted in Europe. 
Meta-analyses were not considered appropriate for this 
review owing to the heterogeneity of methodology and 
the broad range of outcomes and outcome measures 
used across the original studies. The review compares 
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FIGURE 3.1
Flow chart of the search process and number of records identified, retained and excluded at each phase
Records identification phase
(n = 997)
Titles identified through database search
(n = 997)
WoS: 968
PubMed: 5 (additional)
Drugscope: 24 (additional)
Abstracts review phase
(n = 185)
Abstracts identified  
through previous literature  
review scanned for  
relevance by two reviewers
(n = 30)
Abstracts reviewed by two reviewers
(n = 155)
WoS: 134
PubMed: 5 (additional)
Drugscope: 16 (additional)
Papers review phase
(n = 73)
CONTROLLED STUDIES
Full papers reviewed by two reviewers
(n = 45)
WoS: 24
PubMed: 2 (additional)
Drugscope: 2 (additional)
Reference lists: 17
OBSERVATIONAL STUDIES
Full papers reviewed by two reviewers
(n = 28)
WoS: 11
PubMed: 2 (additional)
Drugscope: 1 (additional)
Reference lists: 14
Papers excluded
(n = 17)
No controlled design: n = 9
Secondary analysis of  
previously published data: n = 5
Analysis of outcome correlates:  
n = 2
During-treatment outcome: n = 1
Titles excluded
(n = 812)
Abstracts excluded
(n = 112)
Papers retained 
(n = 28)
Papers retained 
(n = 21) Papers excluded
(n = 7)
During-treatment  
outcome: n = 5
Secondary analysis of  
previously published  
data: n = 2
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TABLE 3.1
Controlled studies included in this review (n = 28), presented in chronological order (from most recent to oldest), 
geographical area and indication of inclusion in previous reviews
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 1.  Sacks, S., Chaple, M., Sacks, J. Y., McKendrick, K. and Cleland, M. (2012), 
‘Randomized trial of a re-entry modified therapeutic community for offenders with 
co-occurring disorders: crime outcomes’, Journal of Substance Abuse Treatment 42, 
pp. 247–259. 
USA
 2.  Zhang, S. X., Roberts, R. E. L. and McCollister, K. E. (2011), ‘Therapeutic Community 
in a California prison: treatment outcomes after 5 years’, Crime and Delinquency 57, 
pp. 82–101. 
USA
 3.  Messina, N., Grella, C. E., Cartier, J. and Torres, S. (2010), ‘A randomized 
experimental study of gender-responsive substance abuse treatment for women in 
prison’, Journal of Substance Abuse Treatment 38, pp. 97–107. 
USA
 4.  Welsh, W. N. (2007), ‘A multisite evaluation of prison-based therapeutic community 
drug treatment’, Criminal Justice and Behavior 34, pp. 1481–1498.
USA
 5.  Sullivan, C. J., McKendrick, K., Sacks, S. and Banks, S. (2007), ‘Modified therapeutic 
community treatment for offenders with MICA disorders: substance use outcomes’, 
American Journal of Drug and Alcohol Abuse 33, pp. 823–832.
USA
 6.  Morral, A. R., McCaffrey, D. F. and Ridgeway, G. (2004), ‘Effectiveness of community-
based treatment for substance-abusing adolescents: 12-month outcomes of youths 
entering Phoenix Academy or alternative probation dispositions’, Psychology of 
Addictive Behaviors 18, pp. 257–268.
USA
 7.  Sacks, S., Sacks, J. Y., McKendrick, K., Banks, S. and Stommel, J. (2004), ‘Modified 
TC for MICA offenders: crime outcomes’, Behavioral Sciences and the Law 22, 
pp. 477–501.
USA • •
 8.  Inciardi, J. A., Martin, S. S. and Butzin, C. A. (2004), ‘Five-year outcomes of 
therapeutic community treatment of drug-involved offenders after release from 
prison’, Crime and Delinquency 50, pp. 88–107.
USA
 9.  Prendergast, M. L., Hall, E. A., Wexler, H. K., Melnick, G. and Cao, Y. (2004), ‘Amity 
prison-based therapeutic community: 5-year outcomes’, Prison Journal 84, 
pp. 36–60.
USA
10.  Prendergast, M. L., Hall, E. A. and Wexler, H. K. (2003), ‘Multiple measures of 
outcome in assessing a prison-based drug treatment program’, Journal of Offender 
Rehabilitation 37, pp. 65–94.
USA
11.  Greenwood, G. L., Woods, W. J., Guydish, J. and Bein, E. (2001), ‘Relapse outcomes 
in a randomized trial of residential and day drug abuse treatment’, Journal of 
Substance Abuse Treatment 20, pp. 15–23.
USA •
12.  De Leon, G., Sacks, S., Staines, G. and McKendrick, K. (2000), ‘Modified therapeutic 
community for homeless mentally ill chemical abusers: treatment outcomes’, 
American Journal of Drug and Alcohol Abuse 26, pp. 461–480. 
USA
13.  French, M. T., Sacks, S., De Leon, G., Staines, G. and McKendrick, K. (1999), 
‘Modified therapeutic community for mentally ill chemical abusers: outcomes and 
costs’, Evaluation and the Health Professions 22, pp. 60–85.
USA
14.  Wexler, H. K., De Leon, G., Thomas, G., Kressel, D. and Peters, J. (1999), ‘The Amity 
prison TC evaluation’, Criminal Justice and Behavior 26, pp. 147–167.
USA • •
15.  Guydish, J., Sorensen, J. L., Chan, M., Werdegar, D., Bostrom, A. and Acampora, A. 
(1999), ‘A randomized trial comparing day and residential drug abuse treatment: 
18-month outcomes’, Journal of Consulting and Clinical Psychology 67, 
pp. 428–434. 
USA • •
16.  Nemes, S., Wish, E. D. and Messina, N. (1999), ‘Comparing the impact of standard 
and abbreviated treatment in a therapeutic community. Findings from the district of 
Columbia treatment initiative experiment’, Journal of Substance Abuse Treatment 
17, pp. 339–347. 
USA • • •
17.  Martin, S., Butzin, C. A., Saum, C. A. and Inciardi, J. A. (1999), ‘Three year outcomes 
of therapeutic community treatment for drug-involved offenders in Delaware’, Prison 
Journal 79, pp. 291–320.
USA •
18.  Nuttbrock, L. A., Rahav, M., Rivera, J. J., Ng-Mak, D. S. and Link, B. G. (1998), 
‘Outcomes of homeless mentally ill chemical abusers in community residences and 
a therapeutic community’, Psychiatric Services 49, pp. 68–76.
USA •
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19.  Guydish, J., Werdegar, D., Clark, W., Sorensen, J. L. and Acampora, A. (1998), ‘Drug 
abuse day treatment: a randomised clinical trial comparing day and residential 
treatment programs’, Journal of Consulting and Clinical Psychology 66, pp. 
280–289.
USA •
20.  McCusker, J., Bigelow, C., Frost, R., Garfield, F., Hindin, R., Vickers-Lahti, M. et al. 
(1997a), ‘The effects of planned duration of residential drug abuse treatment on 
recovery and HIV risk behaviour’, American Journal of Public Health 87, 
pp. 1637–1644.
USA • •
21.  Lockwood, D., Inciardi, J. A., Butzin, C. A. and Hooper, R. M. (1997), ‘The therapeutic 
community continuum in corrections’, in: De Leon, G. (ed.), Community as method. 
Therapeutic communities for special populations and special settings, Praeger, 
Westport, CT, pp. 87–96. 
USA •
22.  Hartmann, D. J., Wolk, J. L., Johnston, J. S. and Colyer, C. J. (1997), ‘Recidivism and 
substance abuse outcomes in a prison-based therapeutic community’, Federal 
Probation 61, p. 18–25.
USA
23.  Nielsen, A. L., Scarpitti, F. R. and Inciardi, J. A. (1996), ‘Integrating the therapeutic 
community and work release for drug-involved offenders: the Crest program’, 
Journal of Substance Abuse Treatment 13, pp. 349–358.
USA •
24.  McCusker, J., Stoddard, A., Frost, R. and Zorn, M. (1996), ‘Planned versus actual 
duration of drug abuse treatment. Reconciling observational and experimental 
evidence’, Journal of Nervous and Mental Disease 184, pp. 482–489. 
USA •
25.  McCusker, J., Vickers-Lahti, M., Stoddard, A., Hindin, R., Bigelow, C., Zorn, M., et al. 
(1995), ‘The effectiveness of alternative planned durations of residential drug abuse 
treatment’, American Journal of Public Health 85, pp. 1426–1429.
USA •
26.  Bale, R. N., Zarcone, V.P., Van Stone, W. W., Kuldau, J. M., Engelsing, T. M. J. and 
Elashoff, R. M. (1984), ‘Three therapeutic communities — a prospective controlled 
study of narcotic addiction treatment — process and 2 year follow-up results’, 
Archives of General Psychiatry 41, pp. 185–191. 
USA
27.  Coombs, R. H. (1981), ‘Back on the streets: therapeutic communities’ impact upon 
drug users’, American Journal of Drug and Alcohol Abuse 8, pp. 185–201. 
USA
28.  Bale, R. N., Van Stone, W. W., Kuldau J. M., Engelsing, T. M., Elashoff, R. M. and 
Zarcone, V. P. (1980), ‘Therapeutic communities vs. methadone-maintenance 
— prospective controlled study of narcotic addiction treatment — design and one 
year follow-up’, Archives of General Psychiatry 37, pp. 179–193.
USA •
Seventeen articles were excluded for the following 
reasons: the study had not used a controlled design 
(n = 9); report of secondary analyses of previously 
published data (n = 5); analysis of outcome correlates 
(n = 2); and only during-treatment outcomes reported 
(n = 1). Full references to all studies that were excluded 
in this phase are listed in Annex C alongside the country 
where recruitment took place, and the reason for 
exclusion from this review.
The 28 included papers (Table 3.2) were based on a total 
of 16 unique studies (papers derived from one study 
were accessed and included when they reported 
different outcomes and/or follow-up periods) [e.g. the 
Delaware studies (Lockwood et al., 1997; Martin et al., 
1999; Inciardi et al., 2004) and the Amity prison TC 
studies (Wexler et al., 1999; Prendergast et al., 2003; 
Prendergast et al., 2004)].
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TABLE 3.2
Type of comparison group studied (refer to study codes)
Type of comparison group
Controlled studies
Community or 
prison TC?
Study Study code
Substance 
use outcome
Criminal 
offences
Between-group difference 
on outcomes of TC treatment 
provided in different setting
Prison TC Messina et al. (2010) A •
Martin et al. (1999) B • •
Lockwood et al. (1997) C • •
Community TC Greenwood et al. (2001) D •
Guydish et al. (1998) E
Guydish et al. (1999) F
Nemes et al. (1999) G • •
De Leon et al. (2000) H • •
McCusker et al. (1997a) I • •
McCusker et al. (1995) J
McCusker et al. (1996) K •
French et al. (1999) L • •
Coombs (1981) M •
TC treatment with no 
treatment
Prison TC Zhang et al. (2011) N •
Morral et al. (2004) O • •
Inciardi et al. (2004) P • •
Nielsen et al. (1996) Q • •
Prendergast et al. (2004) R • •
Prendergast et al. (2003) S • •
Wexler et al. (1999) T •
Hartmann et al. (1997 U • •
Community TC Nuttbrock et al. (1998) V •
TC treatment with usual care Prison TC Sacks et al. (2012) W •
Welsh (2007) X • •
Sullivan et al. (2007) Y •
Sacks et al. (2004a) Z •
Community TC Bale et al. (1984) A1 • •
Bale et al. (1980) B1 • •
The oldest controlled studies date from the beginning of 
the 1980s (M, A1, B1) and the bulk of studies were 
performed or published in the 1990s. All controlled 
studies were performed in the USA. Despite a growing 
research tradition in European, Australian and South 
American TCs, only observational studies, and no 
controlled research, have been set up and carried out on 
these continents. Retrieved (but excluded) non-US 
studies had applied (retrospective) cohort study designs 
(e.g. Toumbourou et al., 1998). Since the publication of 
the Smith et al. (2006) review on TC effectiveness, two 
randomised and three non-randomised controlled 
studies have been published, all carried out in TCs in 
correctional settings.
Thirteen papers (studies A to M inclusive) reported 
between-group differences in the outcomes of TC 
treatment provided in different settings [(e.g. community 
TC vs. day TC, e.g. study E) or of TCs of different 
intensity or length, (e.g. study J)]. In the latter case, the 
longer or most comprehensive TC programme was 
regarded as the experimental condition. Nine reports 
compared TC treatment with no treatment (studies N to 
V inclusive). Six comparisons were identified of TC 
treatment with some form of usual care (e.g. case 
management, standard treatment) (studies W to B1 
inclusive). Some comparisons reported in the literature 
(e.g. study B) included multiple control conditions, 
although significant between-group differences could 
typically be identified when comparing the most 
intensive with the least intensive treatment condition.
As shown in Table 3.2, more controlled research that 
was eligible for inclusion in this review has studied 
prison-based TC treatment outcomes than community 
TC treatment outcomes. While a substantial number of 
drug users may enter community TC treatment under 
legal pressure, TC treatment in prisons has to be 
regarded in a rather different context given the 
compulsory custody and conditional release term and 
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Abstinence was a measure of choice in four of the trials 
(B, C, P, U), and relapse or time to relapse was measured 
and reported by one (Q) and two papers (S, Y), 
respectively. Reported abstinence following prison TC 
treatment was consistently high — 85.4 % and 87 % at 
5- and 6-month follow-up, respectively (C,U) — but 
treatment gains seemed to have diminished by 18 
months after treatment was completed, with relapse 
reported at 51.7–69 % (B, Q).
Community TCs
Of 11 papers reporting outcomes in this domain, the 
findings of eight (D, G, H, K, M, V, A1, B1) suggested that 
TC participants had a significantly better outcome in at 
least one outcome measure, or at one time point, 
compared with control conditions. Across the studies, 
substance use was measured as self-reported reduction 
in drug use (G, H, L, B1) or using a urine drug screen (V); 
abstinence (D, M, A1); relapse (J, K, M); or time to 
relapse (I).
With regard to short-term as well as longer-term 
outcome, community residential TC participants were 
reported to have fared better than control groups at the 
6-month follow-up (D, I, J), and the gains appeared to 
have been maintained as evidenced by measurement at 
the 12-, 18- and 24-month points. These superior results 
for the TC groups reached statistical significance in half 
or more of the reports at each time point [6-month 
follow-up (D, K); 12-month follow-up (H, L, M, V, B1 ); 
18-month follow-up (G); and 24-month follow-up (H, A1)].
Criminal offences
Prison TCs
With regard to the criminal offence outcomes of prison 
TCs, of the 14 papers that assessed this outcome 
domain, 11 (B, C, P, Q, R, S, T, U, W, X, Z) reported that at 
follow-up (5–60 months after release), prison TC 
participants fared significantly better than incarcerated 
drug users who participated in some form of usual 
prison drug treatment or received no treatment during 
incarceration. Three papers (A, N, O) reported no 
significant between-group differences at follow-up (6 
and 12 months) in that domain.
The majority of studies found a positive impact of TC 
treatment on diverse criminal offence outcomes, 
including recidivism, re-arrest and reincarceration. 
Reincarceration rates 12 to 18 months after release 
privileges. For this reason, and where available evidence 
would allow it, results are presented separately for 
community and prison settings.
Retention in treatment and treatment completion
Where study participant recruitment has occurred at the 
start of TC treatment rather than at the point of treatment 
departure (treatment completion or dropout), studies 
have been in the position to assess retention in treatment 
— four trials reported retention in treatment, using 
measures of ‘days in treatment’ (D, E) or ‘6-month 
retention in treatment’ (E) and ‘12-month retention in 
treatment’ (F, V). In addition to treatment retention, 
completion of the planned treatment programme was 
evaluated in four reports (G, I, K, M), all of which yielded 
non-significant between-group differences when 
comparing standard (12-month programme) with 
abbreviated 3-month (K) or 6-month (G) programme TCs.
According to the available data, TC participants fare 
worse than controls with regard to treatment retention 
and completion of treatment. Substantial dropout has 
been observed in most long-term TC programmes, 
especially in the early phases of treatment (study F). 
Studies that have compared long- and short-term TC 
programmes usually found lower completion rates in the 
longer programmes (I, V).
Substance use
In the substance use outcome domain, across the 
articles included in this review, the main interest was in 
three measures: (1) self-reported primary drug use, 
operationalised in various ways from ‘complete 
abstinence’ towards ‘reduced drug use at follow-up’; (2) 
relapse to drug use; and (3) time to relapse.
Prison TCs
Considering prison TCs only, of the 11 papers that 
reported the substance use treatment outcome, the 
results of eight (B, C, O, P, Q, S, U, Y) suggested that TC 
subjects fare significantly better at follow-up, and in the 
other three no significant between-group differences 
were reported at 6-, 12-, 24- (A, X) and 60-month (R) 
follow-up in this outcome domain.
Five trials (A, O, R, X, Y) measured changes in drug (and 
alcohol) use, employing some form of self-report, with 
the exception of Study X, where urine drug screen 
results were used to measure drug use outcome. 
Therapeutic communities for treating addictions in Europe
50
lower rates of relapse to drug use or criminal activity 
were associated with longer treatment exposure (H, K, 
M, Q, A1), participation in aftercare (N, P, T), post-
treatment employment (X) and older age (P, R). 
Completing the planned TC treatment programme was 
associated with better treatment outcome in those who 
completed the TC programme compared with dropouts 
(R, T). Dropout during and relapse after treatment was 
predicted in at least two studies by the severity of 
substance use at baseline (P, V).
Employment and other outcomes
A number of controlled studies have explored outcomes 
beyond substance use and criminal activity. All of the 
seven studies that reported between-group comparisons 
in the domain of employment (G, H, I, R, X, A1, B1 ) 
detected a significantly better employment situation in 
TC participants compared with recipients of other 
treatment modalities (e.g. study X) or no treatment while 
on a waiting list (e.g. study R).
Of the seven studies that explored other outcomes 
[family functioning (study A); physical and mental health 
(studies E, F, L, O, R); mortality (study A1)], only Messina 
et al. (study A) and Prendergast et al. (study R) reported 
no statistically significant between-group differences at 
follow-up. In the remaining studies, TC participants were 
consistently reported to have fared significantly better in 
terms of social functioning, health and survival at 
follow-up compared with control groups.
I 3.2.2. Observational studies
A total of 28 potentially eligible papers reporting 
observational studies conducted in Europe were 
identified, of which 21 were retained as meeting the 
inclusion criteria of this review (Table 3.3).
were between 30 % and 55 % in most studies, although 
Sacks and colleagues reported lower rates [modified TC 
19 % vs. parole supervision 38 % (W); prison modified 
TC 9 % vs. standard prison treatment 33 % (Z)]. Longer-
term follow-up of prison TC participants indicated a 
reincarceration rate of 76 % vs. 83 % in the control group, 
at five-year post release follow-up (R).
Time to re-arrest (days to first illegal activity after 
release) was a reported outcome in five papers (A, G, R, 
S, W). Although time to event was significantly longer in 
the TC group than in the control group in two reports 
[time to re-arrest — standard TC 9.4 months vs. 
abbreviated TC 6.9 months (G); days to first illegal 
activity — prison TC 138 days vs. no treatment 71 days 
(S)], another two reported significant between-group 
differences in favour of the control conditions studied 
[days to reincarceration — modified TC 161 vs. parole 
supervision 168 (W); days to reincarceration — prison 
TC 634 vs. no treatment 809 (R)], and one study did not 
identify significant between-group differences [return to 
custody — prison modified TC 31 % vs. standard prison 
TC 45 % (A)].
Community TCs
The criminal offence outcome domain has been 
considerably less well evaluated among community TC 
participants, with six papers reporting criminal activity 
outcome (G, H, I, L, A1, B1). The findings in five papers 
(G, H, L, A1, B1) suggested that TC participants had a 
significantly better outcome on at least one outcome 
measure or at one time point compared with control 
conditions [reduced self-reported criminal activity or 
criminal problems (H, L); re-arrest (G, B1); conviction 
(A1, B1)].
Predictors of post-treatment substance use and 
criminal offences
Although correlates of treatment outcome were not in 
the focus of the present review, it should be noted that 
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TABLE 3.3
Observational studies included in this review (n = 21), presented in chronological order (from most recent to oldest) 
and geographical area
Full study reference Country
 1.  Lopez-Goni, J., Fernández-Montalvo, J., Menéndez, J.C., Yudego, F., García, A. and Esarte, S. (2011), 
‘Employment integration after therapeutic community treatment: a case study from Spain’, International Journal 
of Social Welfare 20, pp. 292–297.
Spain
 2.  Lopez-Fernandez, O., Ferrer-Perez, X., Lafarga-Lebey, S., Honrubia-Serrano, M. L. and Tudela-Mari, M. (2011), 
‘Follow-up of alcohol and/or cocaine dependents after their discharge from a Therapeutic Community: a pilot 
study’, Adicciones 23, pp. 289–298.
Spain
 3.  Lopez-Goni, J., Fernández-Montalvo, J., Menéndez, J. C., Yudego, F., García, A. and Esarte, S. (2010), ‘Group and 
individual change in the treatment of drug addictions: a follow-up study in therapeutic communities’, Spanish 
Journal of Psychology 13, pp. 906–913.
Spain
 4.  Salamina, G., Diecidue, R., Vigna-Taglianti, F., Jarre, P., Schifano, P., Bargagli, A., Davoli, M. et al. (2010), 
‘Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE 
Study’, Substance Use and Misuse 45, pp. 2076–2092.
Italy
 5.  Davoli, M., Bargagli, A., Perucci, C., Schifano, P., Belleudi, V., Hickman, M. et al. (2007), ‘Risk of fatal overdose 
during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study’, 
Addiction 102, pp. 1954–1959. 
Italy
 6.  Fernandez-Montalvo, J., Lopez-Goni, J., Illescas, C., Landa, N. and Lorea, I. (2008), ‘Evaluation of a therapeutic 
community treatment program: a long-term follow-up study in Spain’, Substance Use and Misuse 43, pp. 
1362–1377.
Spain
 7.  Quercioli, C., Fini, P., Morgagni, S., Frola, C., Carraro, D., Carioli, R., Spinella, V. et al. (2007), ‘Effectiveness of drug 
addicted therapeutic community: long term follow-up’, European Journal of Public Health 17, pp. 116–117.
Italy
 8.  Quercioli, C., Fini, P., Morgagni, S., Frola, C., Carraro, D., Carioli, R., Spinella, V., Longo, L. et al. (2006), 
‘Effectiveness evaluation of drug addicted therapeutic community’, European Journal of Public Health 16, 
p. 126. 
Italy
 9.  Berg, J. E. (2003), ‘Mortality and return to work of drug abusers form therapeutic community treatment 3 years 
after entry’, Primary Care Companion Journal of Clinical Psychiatry 5, pp. 164–167.
Norway
10.  Fernandez-Hermida, J. R., Secades-Villa, R., Fernandez-Ludena, J. J. and Marina-Gonzalez, P. A. (2002), 
‘Effectiveness of a therapeutic community treatment in Spain: a long-term follow-up study’, European Addiction 
Research 8, pp. 22–29.
Spain
11.  Keen, J., Oliver, P., Rowse, G. and Mathers, N. (2001), ‘Residential rehabilitation for drug users: a review of 13 
months’ intake to a therapeutic community’, Family Practice 18, pp. 545–548. 
UK
12.  Fredersdorf, F. (2000), ‘Synanon in Germany: an example of a residential self-help organization for drug 
dependent individuals’, International Journal of Self Help and Self Care 1, pp. 131–143.
Germany
13.  Van de Velde, J. C., Schaap, G. E. and Land, H. (1998), ‘Follow-up at a Dutch addiction hospital and 
effectiveness of therapeutic community treatment’, Substance Use and Misuse 33, pp. 1611–1627.
Netherlands
14.  Ravndal, E. and Vaglum, P. (1998), ‘Psychopathology, treatment completion and 5 years outcome: a prospective 
study of drug abusers’, Journal of Substance Abuse Treatment 15, pp. 135–142.
Norway
15.  Ravndal, E. and Vaglum, P. (1992), ‘HIV positive drug abusers in a hierarchical therapeutic community. A 
prospective study’, Nordic Journal of Psychiatry 46, pp. 307–314.
Norway
16.  Kooyman, M. (1992), The Therapeutic Community for addicts: intimacy, parent involvement and treatment 
outcome, Universiteitsdrukkerij Erasmusuniversiteit, Rotterdam.
Netherlands
17.  Uchtenhagen, A. and Zimmer-Höffler, D. (1987), ‘Psychosocial development following therapeutic and legal 
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reported different outcomes, e.g. Lopez-Goni et al., 2010, 
2011) — for more details see Annex B. All papers 
reported research conducted in west European 
countries. At the time of writing of this report, one study 
using an observational design and evaluating TC 
treatment outcome in the Czech Republic has been 
concluded. As descriptive data from this research were 
accessed only by the review team, this study was not 
included in subsequent reporting on this occasion.
Seven papers were excluded from this review for the 
following reasons: only during-treatment outcomes 
reported (n = 5); report of secondary analyses of 
previously published data (n = 1); and analysis of 
outcome correlates (n = 1) (see Annex F).
The 21 included papers (Table 3.4) were based on a total 
of 14 unique studies (a number of papers derived from 
one study were accessed and included where they 
TABLE 3.4
Details of observational studies included in the review
Type of study design
Observational studies
Study Study code
Substance use 
outcome
Criminal 
offences
Retrospective cohort Lopez-Goni et al. (2011) A
Lopez-Goni et al. (2010) B •
Fernandez-Montalvo et al. (2008) C • •
Quercioli et al. (2007) D •
Quercioli et al. (2006) E
Berg et al. (2003) F •
Keen et al. (2001) G
Fredersdorf (2000) H •
Wilson and Mandelbrote (1978a) I •
Wilson and Mandelbrote (1978b) J
Ogborne and Melotte (1977) K •
Retrospective sequential cohort Fernandez-Hermida et al. (2002) L • •
Prospective cohort Lopez-Fernandez et al. (2011) M •
Salamina et al. (2010) N
Davoli et al. (2007) O
Ravndal and Vaglum (1998) P •
Van de Velde et al. (1998) Q • •
Kooyman (1992) R •
Ravndal and Vaglum (1992) S
Uchtenhagen and Zimmer-Höffler (1987) T
Wilson and Mandelbrote (1985) U
All reviewed observational studies were published 
between 1977 and 2012. This is a relatively low number 
of publications compared with the multitude of 
observational studies conducted in the USA during the 
same period (De Leon, 2010). With the exception of the 
Italian VEdeTTE (study O), none of the large-scale 
multicentre national drug treatment outcome studies in 
Europe [e.g. the United Kingdom’s National Treatment 
Outcome Research Study (NTORS) or the follow-up to 
NTORS, the Drug Treatment Outcome Research Study 
(DTORS)] has reported data on TCs separately, and for 
that reason they were not considered for review here. All 
retrieved publications reported outcome evaluation of 
standard addiction TCs treatment, and none of the 
papers related to the modified TCs treatment outcome 
for specific populations or prison-based TC treatment 
and outcome.
Outcomes were commonly reported in the domains of 
substance use, employment and social functioning, with 
change assessed between baseline [TC treatment entry 
or at the point of leaving TC treatment (completion or 
dropout)] and follow-up [ranging from 3 months (L) to 13 
years (C)].
Substance use
A measure of abstinence was used in four studies (H, K, 
R, S). These were self-reported data indicating 
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Employment and other outcomes
Overall, change in employment and other treatment 
outcome domains were less frequently addressed than 
substance use and criminal involvement. Alongside 
Fernandez-Montalvo et al. (study C), two other studies 
have looked at changes in the employment status of 
drug users undergoing TC treatment — with reports of 
significant improvement in that domain as measured 
3–96 months after TC treatment (L) or improvement that 
did not reach statistical significance (A).
Five studies (F, O, P, S, U) assessed mortality among TC 
treatment residents between 18 months following the start 
of TC treatment (study O) and 10 years after TC treatment 
was completed (study U). Although no deaths were 
reported to have occurred during TC treatment, the first 30 
days after TC treatment in VEdeTTE saw a rate of 21.6 
deaths per 1 000 person years (study O). Mortality was 
reported at 6.9 % at 36 months’ follow-up (study F), 12.4 % 
at 60 months (study P) and 10 % at 10 years (study U).
I 3.3. Summary
We reviewed the international controlled (randomised 
and quasi-experimental) studies and European 
observational (prospective or retrospective cohort) 
studies evaluating TC treatment outcome. Across the 
articles included in the review, the main interest was in 
three measures. One measure was (a) self-reported 
primary drug use (which itself has been measured in 
various ways which captures what might be termed 
‘complete abstinence’ and also might capture a different 
measure of ‘reduced drug use at follow-up’); (b) criminal 
activity involvement measures; (c) death/survival/
mortality; and (d) social integration.
Based on this review and analyses of controlled and 
observational studies, it can be concluded that there is 
some evidence for the effectiveness of TC treatment, at 
least in the USA, in terms of reduced substance use and 
criminal activity. Although death is an important and 
powerful measure, as the event is so rare it has not been 
chosen as the primary outcome in any of the (quasi-)
experiments. A small number of studies also showed 
positive effects on employment, social functioning and 
general mental health. While positive treatment 
outcomes strongly correlate with treatment completion, 
TCs are overall less effective than other interventions 
with respect to treatment retention.
TC outcome research in Europe is limited to field 
effectiveness studies. Generally, these studies identify 
abstinence of 17 % at 6 months (study K), 32 % at 49 
(± 12) months (study R) and 20 % at 60 months 
following TC treatment (study P). Fredersdorf’s 
assessment of abstinence (study H) was reported at 
about 60 %, although a time point was not easy to assign 
as evaluation occurred at any time between 12 and 60 
months post treatment.
Where self-reported reduction in substance use was 
used to measure change in this outcome category  
(B, L, M, Q), studies consistently reported that 
considerable (non-statistically significant) to statistically 
significant reductions in drug and/or alcohol use 
occurred and were maintained during the follow-up 
periods. Studies C, D and F used a measure of relapse to 
drug use, with D and F reporting 23.8 % at 36 months 
post treatment and 41 % at 96 months, respectively. One 
study (E) used a validated measure of problem severity 
(ASI: Addiction Severity Index; McLellan et al., 1992) to 
track changes in substance use over 96 months post TC 
treatment — and detected a significant reduction in this 
domain over the follow-up period.
Criminal offences
In the criminal activity outcome domain, three studies  
(C, I, L) used a measure of re-arrest/reconviction, 
consistently — studies I and L noted statistically significant 
reductions in re-arrest/reconviction. Study Q used changes 
in self-reported legal problems as the outcome measure, 
reporting pre- to post-treatment reductions.
Predictors of post-treatment substance use and 
criminal offences
Although most studies indicated improved substance 
use and criminal involvement outcomes after TC 
treatment, not all participants were reported to benefit 
equally from this type of treatment. Most notably, TC 
treatment effect has been related to the length of stay in 
treatment and the completion of the planned duration of 
the treatment programme. Outcome difference between 
treatment completers and dropouts explored by 
Fernandez-Montalvo and colleagues (study C) noted that 
significantly greater treatment advantages were secured 
during treatment and maintained up to 13 years after TC 
treatment by residents who completed treatment versus 
dropouts. Similar superior gains with regard to 
substance use reduction were identified 9 to 15 months 
after TC treatment among TC treatment completers 
compared with dropouts (study B). Comparable 
differences were also observed in the employment 
outcome domain (study C).
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fidelity, whereas traditional community-based TC 
programmes rarely, if at all, follow manuals or monitor 
fidelity. This would, however, be necessary to support 
claims that results could be generalised. Moreover, TCs 
often present moving targets, with services and staffing 
changing (see Chapter 2) along with changes in the 
treatment funding environment.
Although the effectiveness of community TCs is a 
clinical issue of utmost importance, the field is not yet 
mature enough in terms of the number of available 
controlled studies to be able to address this issue. TC 
studies in Europe are limited to observational studies, 
which provide the empirical groundwork for more 
advanced scientific knowledge on TC treatment (De 
Leon, 2010). At present, our knowledge is based on 
evidence of effectiveness from one US-controlled study 
since the turn of the century. The rest of the controlled 
research was conducted some 15–20 years ago on the 
long-term residential TC model. Thus, further research 
would be needed to establish the effectiveness of TC 
treatment. The field desperately needs a RCT with a 
well-defined population and a standardised treatment 
programme. Even one small, tightly controlled study 
under effectiveness conditions (routine clients, clinicians 
and programmes) would be a considerable step forward. 
Careful attention to engagement and retention of clients 
in treatment will be necessary to achieve a successful 
trial. Given the promising results of TC treatment on 
social reintegration and the growing interest in recovery 
as a treatment objective beyond stabilisation and 
improved health conditions, such an investment might 
be worthwhile under the existing financial conditions.
I 3.4. Limitations
This review is subject to several limitations. First, all 
selected studies have been published in peer-reviewed 
journals — and, while this presents some form of quality 
control, it may have introduced a selection bias as the 
likelihood of retrieving non-English-language articles 
might have been limited in this way. Nonetheless, 
published reports of TC outcome research conducted in 
Spain, Italy and Norway were accessed.
Second, across the studies, substance use and criminal 
activity involvement outcomes were commonly 
measured by self-report, which may not be the most 
accurate measurement approach, as self-reports are 
subject to a number of well-known biases (Morral et al., 
2000). Nonetheless, there is some evidence to suggest 
that verbal self-report procedures in research can 
provide useful estimates of consumption in clinical 
positive treatment outcome, associated with longer 
retention in treatment and treatment completion, 
although these studies have major methodological 
problems.
Overall, the methodological quality of the included 
observational studies is unsatisfactory relating to, inter 
alia, small sample sizes and high attrition rates. None of 
the large national multicentre studies has reported TC 
outcomes separately, so there is a major gap in our 
knowledge on the effectiveness of TC treatment delivery 
in Europe. Owing to the nature of observational research 
design, changes in drug use or criminal involvement 
behaviours cannot be attributed to the receipt of 
treatment, as opposed to maturation of the studied 
cohorts or ‘natural recovery’ (Shadish et al., 2002). 
To some extent, these confounds could be readdressed 
by comparing the relative effectiveness of different 
programmes. For instance, assuming that individuals 
entering residential TC and day TC programmes are 
similar and subject to the same processes of maturation 
and natural recovery, any differences in outcome 
associated with residential TC or day TC might be 
considered a candidate treatment effect. The 
assumption, however, that drug users entering different 
programmes are similar is contradicted by the available 
data. Each major observational study of drug treatment 
has found significant differences among treatment 
groups on pre-treatment characteristics such as 
problem severity, treatment motivation, criminal history 
and social environment. As all these factors reliably 
correlate with TC treatment outcome [e.g. Fernandez-
Hermida et al. (2002), Lopez-Goni et al. (2010, 2011)], 
comparisons of treatments have to take into account 
such group differences.
Few community-based TCs have been studied using 
rigorous evaluation designs that control for pre-
treatment differences between TC-treated individuals 
and comparison condition groups. Since the turn of the 
century, only one controlled study of community TC 
treatment outcome has been conducted (Greenwood et 
al., 2001) using a quasi-experimental design that 
included a comparison group (of day TC clients) more or 
less well matched with the residential TC treatment 
group. The observation that community TCs have 
received less rigorous evaluations than prison TCs and, 
more notably, that have more recent or novel treatment 
approaches (e.g. OST, supervised injectable heroin 
treatment) may partly be because of general concerns 
about the generalisability of community-based 
treatment or non-medication-based treatment. The 
approaches more commonly subject to rigorous 
evaluation are provided with ongoing and/or intensive 
supervision and training to ensure implementation 
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allow retention of all study recruits in the statistical 
analyses, should be considered, in order to answer 
questions about post-treatment patterns of non-drug 
use, sustained positive quality of life, and other changes 
relevant to the individual, his or her family and close 
networks and society at large.
I 3.5. Conclusions
The most obvious benefits of TC treatment over other 
interventions are lower substance use and recidivism 
rates in more than half of all selected studies, although 
the nature of the findings was not unequivocal across all 
controlled studies, and sample characteristics differed 
greatly. These positive findings have consistently been 
found in prison and community settings, regardless of 
the type of controls. In several studies modified TCs 
appeared to produce superior outcomes compared with 
standard TC treatment, illustrating the need for TC 
programmes to evolve and adapt to new developments 
and changing populations. Follow-up periods varied 
greatly, but outcomes were usually measured after 
12–18 months. A small number of studies have 
assessed clients’ functioning beyond this period and 
— although significant benefits of TC treatment have 
been found five years later — differential effects 
declined over time.
Treatment in TCs takes time, usually 6–12 months (Lees 
et al., 2004). This lengthy treatment period heightens the 
possibility that patients leave the TC prematurely. 
Furthermore, many drug addicts are not ready for 
long-term drug treatment or are not interested in this 
type of residential group treatment. Treatment in TCs 
should therefore be considered as a specific 
intervention, reserved for drug addicts with multiple and 
severe problems. Although two-thirds of all opiate 
addicts follow outpatient substitution treatment, a 
substantial number of persons may not do well in 
outpatient treatment because of a lack of structure and 
support in the community and the fact that they live in 
neighbourhoods in which drugs are pervasive. In 
addition, individuals may lack the internal control and 
refusal skills to resist craving and social pressure to use 
substances (Drake et al., 2002). For these drug users, 
TCs are supportive places where clients can learn the 
skills conducive to living a sober and rewarding life. Still, 
more information is needed on who benefits most from 
residential treatment and at what point in the recovery 
process.
Research is needed on whether treatment engagement 
can be enhanced by adding an induction programme to 
settings when conditions are designed to maximise the 
accuracy of responses (Del Boca and Darkes, 2003). 
Furthermore, in comparative research, biases in self-
reports should affect only conclusions about outcome 
differences to the extent that individuals in one 
treatment condition are more or less biased in their 
reporting, i.e. biases vary by condition (known as 
differential reporting), which is unlikely to be the case in 
the included controlled studies.
Third, substantial variance from client profiles and 
treatment fidelity need to be acknowledged. TC 
programmes today address the needs of a wide range of 
different drug user populations, such as dually diagnosed 
clients and other specific client groups — and, related to 
that, a variety of treatment components and modifications 
in terms of programme length, intensity and delivery 
setting have been introduced. This heterogeneity has also 
been recognised in previous reviews (e.g. Smith et al., 
2006; De Leon, 2010) and should be taken into account 
when reading the TC literature. Nonetheless, the TC is an 
internationally accepted addiction treatment method with 
distinctive features (Chapter 1), shared to a lesser or 
greater extent by all TC programmes, which allows the 
collective review of TC research, as well as review of the 
clinical experience with this treatment modality across 
countries and cultures (Goethals et al., 2011). Although 
the underlying elements may be fairly similar across TC 
programmes, the dose of the programme and fidelity to 
the TC concept may vary considerably. Very few of the 
reviewed studies have included a measure of TC 
treatment fidelity, such as SEEQ [Survey of Essential 
Elements Questionnaire (Melnick and De Leon, 1999)], 
leaving the question open as to the degree of TC 
programme implementation in accordance with 
established TC principles and essential therapeutic 
elements.
Treatment dropout and study attrition may further 
compromise the validity of the results of controlled as 
well as observational studies. Consequently, several 
studies have included only substance users who stayed 
in a TC for a substantial period or who completed 
treatment, but these findings can hardly be generalised 
to all persons starting TC treatment. Drop-out during the 
early phase of TC treatment is a well-documented 
phenomenon and should be taken into account when 
evaluating the effectiveness of TCs (Smith et al., 2006).
Smith and colleagues (2006) have suggested that large 
pragmatic studies, which evaluate objective outcomes 
that can be easily followed up for everyone randomised 
(e.g. based on national health registers), should be set 
up to minimise the number of missing data. Also, survival 
analyses, that is, the use of time to event outcome to 
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programmes, it is difficult to justify referral to residential 
TCs of clients who would respond to less intensive 
services. However, because the treatment and care of 
clients at the more severe end of the spectrum (e.g. dual 
disorder clients who are frequently homeless, 
incarcerated or hospitalised) is also very expensive, and 
because they tend to respond poorly to treatment, these 
clients may be good candidates for residential 
treatment. Moreover, a cost analysis (French et al., 1999) 
showed that the most effective TC residential treatments 
cost about the same as outpatient parallel treatment, 
mainly because the clients in outpatient treatment used 
more than twice as many hospital days and eight times 
as many accident and emergency visits as the clients in 
the residential programme.
Given the high costs of the specialised treatment used 
in TCs, evaluation of the cost-effectiveness of European 
TCs is another issue for future research. More research 
is needed not only on the question of whether or not TC 
treatment works but also on what ingredients make it 
work and for which drug addicts is a TC the optimal 
treatment modality. Finally, narrative reviews such as 
this provide a comprehensive overview of the available 
literature, but do not allow us to weigh findings from 
different studies or estimate effect sizes. A meta-
analysis based on the selected controlled studies could 
provide more insight to these unanswered questions.
the TC treatment, shortening the programme length, 
introducing contingency management or motivational 
interviewing or developing outreach strategies. Without 
losing the overall concept of the TC, a more flexible 
approach is needed to answer individual clients’ needs. 
If treatment completion is the best predictor of positive 
outcomes, then TCs need to think about best practices 
for discharge and gradual preparation for the end of 
treatment, so that more residents reach the final phase 
of treatment and complete it.
The results of field effectiveness studies in Europe are in 
line with those from controlled studies, although the lack 
of a control condition and the generally lower 
methodological quality does not allow attribution of 
these findings to the TC treatment per se. While 
controlled studies usually had a follow-up period of no 
more than 12–18 months, field effectiveness studies 
have followed up TC residents for up to five years or 
more after treatment, showing abstinence rates 
between 20 % and 40 %, in particular among persons 
who completed the whole TC programme and who 
stayed in treatment for a substantial period of time.
Because of the variance in client profiles it is yet to be 
established who benefits from TC treatment (and at 
what point in the recovery process). As residential TC 
programmes are more expensive than outpatient 
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Questionnaire (SEEQ; Melnick and De Leon, 1999); 
Service Standards for European TCs for Addiction 
(CofC (3)) and Standards and Goals (WFTC).
I  4.1. Survey of Essential Elements Questionnaire
The SEEQ is an instrument developed in 1999 by 
Melnick and De Leon and is based on the theoretical 
framework of the TC model as described by De Leon 
(1995). The SEEQ was developed as a response to 
increasing concerns about the quality and effectiveness 
of the TC approach (Melnick and De Leon, 1999). It is a 
self-administered instrument consisting of 139 Likert 
scale items with a range from 0 (objectionable) and 1 
(very little importance) to 5 (extremely important) 
(Melnick and De Leon, 1999, p. 309). The instrument has 
six broad dimensions, each of which is divided into a 
number of domains. The dimensions cover the various 
components of TC treatment, whereas the domains 
cover the philosophy and core treatment elements of 
drug-free, hierarchical, concept-based TCs. An overview 
of all dimensions and domains is listed in Table 4.1.
(3)  http://www.drugslibrary.stir.ac.uk/documents/tc.servicestandards.
ed1.pdf
The development and implementation of evidence-
based clinical guidelines and service standards can play 
an important role in quality assurance and improvement 
processes in TCs (EMCDDA, 2011). However, the 
development and implementation of standards and 
guidelines in TCs are subject to serious discussion 
(Lees, 2003). A tension can be observed between 
external pressures for accountability on the one hand 
and the concerns of the TC staff members on the other 
hand. The latter not only are concerned for their clinical 
autonomy but also express doubts about the possibility 
of setting standards for a complex and ever-changing 
therapeutic approach such as the TC. It seems that 
standards developed for TCs are less operational than 
those for medically based treatment approaches (e.g. 
OST) and also need to reflect the daily living and 
learning circumstances of residents in TCs.
In this chapter, available guidelines and standards for TC 
treatment will be presented, based on the results of a 
literature search and information sourced from the 
following international TC bodies: the Community of 
Communities (CofC), the Association of Therapeutic 
Communities, the EFTC and the WFTC.
Three sets of non-country-specific standards and 
guidelines were identified: Survey of Essential Elements 
CHAPTER 4
Therapeutic community standards 
and guidelines
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TABLE 4.1
Dimensions and domains of the SEEQ (*)
Dimension Domains
TC perspective View of the addictive disorder
View of the addict
View of recovery
View of right living
Treatment approach and structure: ‘provides the framework of the therapeutic 
process. Ideally, the structure augments the therapeutic aims and is comprised of the 
managerial procedures consisting of the lines of authority along with the agency’s 
polices, rules and regulations’
Programme organisation
Treatment approach
Staff roles and functions
Clients’ role and functions
Healthcare
Community as therapeutic agent: ‘use of the community as therapeutic agent and 
the strengthening of therapeutic bonds’
Peers as gatekeepers
Mutual help
Community belonging
Contact with the outside community
Positive and negative behavioural 
reinforcement tools (privileges and sanctions)
Educational and work activities: ‘the extent to which both informal and formal 
education and training are included as integral components of the overall program 
and used to support the therapeutic aims’
Formal educational elements
Therapeutic educational elements
Work as therapy
Formal therapeutic elements: ‘these include behavior modifications, group meetings, 
counseling techniques, family in therapy’
General therapeutic techniques
Groups as therapeutic agents
Counselling techniques
Role of the family
Process: ‘rehabilitation in the TC unfolds as a developmental process which may be 
understood as a passage through several stages of incremental learning’
Stages of treatment
Introductory period
Primary treatment stage
Community re-entry period
A recent comparative study (Goethals et al., 2011) that made use of the SEEQ revealed several similarities between European TCs as 
and their American predecessors and revealed that there is — indeed — scientific evidence for the hypothesis that there is an 
underlying ‘generic’ model for TCs for addictions. Goethals et al. (2011, p. 1028) conclude the following:
All TCs subscribe to the same perspective on recovery and right living and strongly adhere to the treatment approach and 
structure, except for educational classes that focus on health issues. They also view peers as gatekeepers that protect 
community values, manage daily activities to endorse community participation, gradually involve the outside community, and 
use sanctions for norms violations. In addition, all TC programs obtain clients’ social and psychological development through 
the use of behavior modification techniques, educational classes, and work. And, finally, they all share a similar perspective on 
the TC process that clients gradually move through three different stages each with their own specific goals and expectations.
(*) Based on an integration of Melnick and De Leon (1999) and Goethals et al. (2011). Text in italics is quoted from Goethals et al. (2011), p. 1030.
I  4.2. Service standards for European therapeutic communities for addiction
The service standards for addiction TCs in Europe were 
conceived and developed as a collaborative project led 
by the Royal College of Psychiatrists, London, UK, with 
the participation and involvement of a diverse group of 
stakeholders from across Europe and beyond (Shah and 
Paget, 2006).
The standards are organised in six sections: core 
standards; physical environment; staff joining and 
leaving; therapeutic environment; treatment programme; 
and external relations. The core standards address vital 
features that all TC programmes should strive to satisfy 
(Table 4.2). The remaining sections address specific 
areas as listed above. The standards represent an ideal 
practice and are to be seen as guiding principles, in that 
not every TC is expected to meet every standard.
The Community of Communities (CofC) network brings 
together TCs from Europe and beyond, engaging them in 
service evaluation and service provision quality 
improvement. At present, the service standards are 
being implemented in the United Kingdom and they have 
the potential to be used on a Europe-wide scale.
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TABLE 4.2
Core service standards
Number Core standard
CS1 The whole community meets regularly 
CS2 All community members work alongside each other on day-to-day tasks
CS3 All community members share social time together
CS4 Members of the community share meals together
CS5 Community members take a variety of roles and levels of responsibility
CS6 Informal aspects of everyday living are integral to the work of the community
CS7 All community members can discuss any aspects of life within the community
CS8 All community members regularly examine their attitudes and feelings towards each other
CS9 All community members share responsibility for each other
CS10 All community members create an emotionally safe environment for the work of the community
CS11 Community members are involved in the selection of new staff members
CS12 All community members participate in the process of a new client member joining the community
CS13 Community members are involved in making plans with a client member for when he or she completes the programme
CS14 There is an understanding and tolerance of disturbed behaviour and emotional expression
CS15 Positive risk taking is seen as an essential part of the process of change
CS16 The therapeutic community has a clear set of boundaries, limits or rules which are understood by all members
Source: Shah and Paget (2006).
I  4.3. Standards and goals of the World Federation of Therapeutic Communities
All TCs that apply for membership of the WFTC are 
required to subscribe and adhere to the WFTC’s 
standards and goals for TCs. By doing so, TCs endorse 
that ‘therapeutic communities represent a design of 
treatment which is directed primarily towards recovery 
from substance abuse through personal growth and 
which requires abstinence from mood-altering 
substances, including prescription drugs used illegally’ 
(WFTC, 2012). Next, the members are required to 
subscribe to a number of standards and goals, as 
described in Table 4.3. These same standards and goals 
were adopted by the EFTC.
TABLE 4.3
Extract from the Standards and Goals for Therapeutic Communities of the WFTC (2012)
The members of the World Federation of Therapeutic Communities are required to:
(a)  Recognise the human and civil rights of all persons associated with their therapeutic community and clearly state the rights, 
privileges and responsibilities of clients and staff.
(b)  Vest in each individual within the therapeutic community the right to be free from the threat of the negative use of power by any 
individual or group.
(c)  Develop a statement on the philosophy and goals of the programme.
(d)  Adopt regulations for their therapeutic community which afford protection from apparent or actual abrogation of local and 
national laws.
(e)  Function within environments which provide maximum opportunity for physical, spiritual, emotional and aesthetic development 
and which will ensure the safety of everyone.
(f)  Facilitate the structure of a society/community-based on the optimal use of the integrity, good will and humanity of all its 
members in which the dignity of persons is a priority value.
(g)  Train and provide adequate supervision for staff.
(h)  Be accountable to an external Executive or Community Board with meetings predetermined and at regular intervals during the 
year for the purpose of maintaining supervision and responsibility for the activities of the programme and each facility.
(i)  Produce an annual audited financial report, authorised by the member’s Executive or Community Board.
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A number of observations and comments are noted 
below on the available TC standards. To date, there is no 
consensus on the definitions or distinctions between 
standards, practices and service goals for TCs. For 
example, WFTC standards and goals emphasise clients’ 
rights, safety and optimal environments which promote 
growth and development and programme accountability. 
These generic requirements do not illuminate the 
standards that relate to the unique clinical and social 
learning features of the TC approach, specifically 
community as method, although the service standards 
for addiction TCs of the CofC (Shah and Paget, 2006; 
CofC, 2012 a,b) and the Czech efforts are promising.
The core standards listed in Table 4.2 do capture 
elements of TCs; if these elements are absent, the 
programme is less likely to be a TC. However, they reflect 
a mixture of structural elements, various practices, 
beliefs, principles, and so on. Definitions and distinctions 
are needed among these terms, as well as the rationale 
(theoretical basis) for each standard.
The topic of standards requires at least a brief discussion 
of TC fidelity, that is, how closely TC programmes adhere 
to the theory, model and method of the TC. Standards 
can be defined as minimum criteria for assuring 
appropriate implementation of TC programmes. The core 
elements (i.e. standards) may be present in a 
programme, but how well they are implemented and/or 
practised further illustrates the issue of TC fidelity. For 
example, a core TC element, the morning meeting, is a 
community activity that meets the minimal criterion 
definition of a TC standard. However, guidelines are 
needed to assure optimal functioning of the morning 
meeting — that is, how and why the morning meeting is 
implemented and whether this activity achieves its 
objective.
This discussion is critical, as the variability in outcomes 
across programmes and cultures may reflect issues 
around how well the TC approach is implemented. 
Indeed, a major limitation in all of the outcome literature 
reviews, including the meta-analytical evaluations, is the 
absence of fidelity assessments. There are models for 
assessing fidelity in terms of both whether or not 
standards are present (such as the CofC) and how well 
standards are implemented/practised. An example of 
the latter may be evaluating whether staff and residents 
understand the reason or rationale for the standard.
A fuller set of national standards and guidelines with 
relevance to TCs is provided in another EMCDDA 
publication (EMCDDA paper on residential treatment for 
drug users in Europe, in press).
I  4.4. Standards and guidelines in the selected countries
In addition to the general guidelines and standards, a 
number of guidelines and standards are being developed 
and implemented by individual countries.
In Spain, Proyecto Hombre, one of the largest drug 
treatment networks in the country, has developed 
manuals and guidelines in order to support evidence-
based treatment in TCs and other treatment modalities. 
The ‘Manual de adicciones para psicólogos especialistas 
en psicología clínica en formación’, coordinated by 
Elisardo Becoña and Maite Cortés (2011), is one such 
example.
In Poland, quality standards were developed by the 
National Bureau for Prevention of Drug Abuse for all 
non-governmental organisations working in the field of 
substance abuse prevention and treatment. The TCs that 
receive funding from this national bureau are obliged to 
comply with these standards (Moskalewicz, 2009). In 
order to be reimbursed by the National Health Insurance 
Fund, residential treatment centres must also comply 
with certain conditions, as included in the law on public 
health institutions and the law on drug prevention. The 
legally defined criteria concern personnel employed, 
professional and ethical standards, types of services 
and some other criteria (Koczurowska, 2006).
In the Czech Republic, the Government Council for Drug 
Policy Coordination (GCDPC) has developed and 
implemented certification standards for a wide range of 
medical, social and medical–social services that are 
active in the field of drug treatment. The standards 
consist of a general and a specific part. The general part 
provides a number of general quality standards, whereas 
the specific part consists of specific standards for each 
type of treatment, e.g. residential care in TCs. In order to 
be certified as a TC, services have to meet a certain 
percentage of all criteria with specific targets related to 
the so-called ‘required’ criteria. Furthermore, the leaders 
of 12 TCs also signed the ethical code of the TC 
Department of the Association of Non-Profit 
Organization (ANO), including an ethical code for the 
staff, a list of clients’ rights and aims and standards of 
TCs. Currently, the implementation process of the 
standards is somewhat disrupted as a result of 
difficulties related to policy coordination between 
ministries and departments, as each department or 
ministry (e.g. health or labour) prefers to apply its own 
criteria and procedures for evaluating quality.
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I 4.5. Conclusion
It is crucial that uniformity is achieved in TC standards 
as well as in the models of TC fidelity assessments. This 
infers consensus on the core elements of the 
programme model, the method and theory (the clinical 
or management rationale) underlying the core elements 
and, although not discussed in this publication, the 
critical implications for uniform training models.
5
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base behind TCs is yet to be strengthened. Mature 
methodologies are yet to be applied to the study of TCs 
in Europe and, to date, the lack of randomised controlled 
studies has prevented TCs from establishing themselves 
as a prominent model of treatment and care, with the 
exception of a few countries in the south and east of 
Europe (e.g. Spain, Italy and Poland) where TC bed 
space is relatively high.
Over recent decades, other (residential) treatment 
modalities have adopted typical TC tools, such as the 
structuring of daily life or the confrontation of one’s 
behaviour during group therapy sessions. TCs have also 
moved into specific niches such as treatment of drug 
users with dual diagnoses, mothers with children, and 
prison inmates.
I  5.2. Therapeutic communities in the future
The future of TCs will depend on how well these 
programmes continue to target areas where they can 
make the most impact and achieve the most good at 
adequate cost. This means continuing the 
implementation of modified TC programmes for 
particularly vulnerable populations, such as the 
homeless and those with co-existing disorders, as well 
as establishing programmes in a range of settings, 
including prison. A few European countries (Spain, 
Romania, the United Kingdom) have introduced TCs to 
the prison setting. While positive outcomes from 
prison-based TCs have been reported in the literature 
from the USA, these findings may not be directly 
translated into the European context — randomised 
controlled studies of European TCs need to be carried 
out to investigate the clinical efficacy and economic 
value of these programmes.
I  5.1. Good times, bad times and new developments
Therapeutic communities (TCs) as defined in this report 
— drug-free, hierarchical, concept-based — are among 
the longest standing treatment modalities for drug 
addicts in Europe. In most European countries, TCs were 
the first treatment solution in response to the emerging 
drug problems in the 1960s and 1970s. Sourced from 
the traditions of democratic TCs and planned 
environment therapy for so-called ‘maladjusted children’ 
(the United Kingdom), psychoanalysis (France) and TC 
treatment for alcohol dependence (the Czech Republic), 
this originally US model has been adapted to the 
European context, adopting its own European TC 
identity (Broekaert, 2006a). TCs promote changes 
towards a drug-free lifestyle through living together in a 
structured way for a substantial period of time. This 
approach was in line with the early drug policies in most 
European countries that focused on total abstinence and 
rehabilitation of drug addicts. Existing institutions were 
not willing or able to treat this new group of persons, 
alternative treatments were not available and a 
considerable number of volunteers involved in TCs 
helped to intervene at limited public cost.
The advent of the HIV/AIDS epidemic in the mid-1980s, 
however, posed new challenges for national drug 
treatment systems. The ever-growing population of drug 
users exhibiting complex clinical profiles and treatment 
needs has prompted the development and growth of 
OST and harm reduction measures to contain the spread 
of drug use-related infectious diseases in Europe. With 
an emphasis on abstinence and a high threshold for 
treatment entry, TCs were driven out into the periphery 
of drug treatment systems.
While the clinical effectiveness and cost-effectiveness of 
OST as a treatment option has been repeatedly 
confirmed using rigorous research designs, the evidence 
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(Broekaert et al., 2006), steered by charismatic 
leadership and not subject to external controls. Today, 
governmental control and adherence to standards such 
as the standards and ethics code formulated by the 
WFTC provide a general framework for TC professionals. 
For accreditation purposes and continued quality 
control, however, more detailed standards are necessary 
and the set of ‘Service Standards for Addiction 
Therapeutic Communities’ developed by the Community 
of Communities (CofC, 2012a, b) is an encouraging 
example. Although quality control in TCs in most 
countries is limited to staffing issues, TCs themselves 
appear to be open to more in-depth and comprehensive 
assessment and accreditation of their services. The 
Survey of Essential Elements Questionnaire’ (De Leon 
and Melnick, 1993; Melnick and De Leon, 1999) is 
potentially a candidate instrument with uses in the 
assessment of TC essential treatment elements, and 
therefore as an indicator of treatment fidelity. This may 
also help to reduce the heterogeneity of the concepts 
provided in Europe under the name of ‘TC’.
In conclusion, TC programmes for the rehabilitation of 
drug users are established in many European countries 
and play a role as part of the national addiction 
treatment systems. There is some evidence for the 
effectiveness of TCs in terms of reduced substance use 
and criminal activity, at least in the USA and a culture of 
TC research is being developed in Europe. This review 
has documented the available evidence and current TC 
practices in the Member States, with a focus on 
improving knowledge and, ultimately, the quality of care 
and service provision in TC programmes in Europe.
While there was a strained relation between abstinence-
oriented and harm reduction programmes during the 
1990s, today TC treatment, OST and harm reduction 
initiatives are increasingly becoming better attuned to 
each other. In fact, they serve the same clients and 
persons in OST today can simultaneously access 
residential TC treatment. If more European facilities 
providing TC interventions are to treat OST clients, it will 
be vital to document treatment outcome as well as 
encouraging collaboration between these services and 
regular screening and monitoring of drug users’ needs. 
While OST has proven its effectiveness with respect to 
health conditions and use of illicit drugs, TCs can look to 
the long-term perspectives of reintegration, social 
inclusion or drug abstinence.
The TC movement has become reconciled to approaches 
that advocate the introduction of shorter programmes 
and outreach and community-based interventions. For 
example, the length of the residential treatment phase 
has been reduced in most countries to around 12 
months or less. A growing emphasis on expenditure 
containment is likely to contribute to further reductions 
in the planned duration of TC treatment episodes, as 
well as a number of other possible changes to the TC 
model and the way it is practised. This includes an 
emphasis on the role of informal volunteers and self-help 
elements at the expense of ‘professional’ staff members, 
akin to North American TC programmes. The ways in 
which the quantity and, more importantly, the quality of 
the TC intervention are negotiated will determine its 
future role in addiction treatment.
Throughout the history of addiction TCs in Europe, a 
number of programmes have been referred to as a sect 
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I Abbreviations used in the annexes
ASI Addiction Severity Index
BDI Beck Depression Inventory
CI confidence interval
HIV human immunodeficiency virus
HR hazard ratio
MMT methadone maintenance treatment
MTC modified therapeutic community
OR odds ratio
Other other therapeutic community modality
PY person years
QES quasi-experimental study
RCI Reliable Change Index
RCT randomised controlled trial
SCL-90-R Symptom Checklist-90-Revised
TAU treatment as usual
TC therapeutic community
TTC traditional therapeutic community
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I  Annex C 
Controlled studies excluded from this review
Full study reference Country Reason for exclusion
 1.  Sacks, J. Y., McKendrick, K., Hamilton, Z., Cleland, C. M., Pearson, F. S. and Banks, S. 
(2008), ‘Treatment outcomes for female offenders: relationship to number of Axis 1 
diagnoses’, Behavioral Sciences and the Law 26, pp. 413–434. 
USA Analysis of outcome 
correlates
 2.  Skinner, D. C. (2005), ‘A modified therapeutic community for homeless persons with 
co-occurring disorders of substance abuse and mental illness in a shelter: an 
outcome study’, Substance Use and Misuse 40, pp. 483–497. 
USA Not a controlled study design
 3.  Sacks, J. Y., McKendrick, K., Pearson, F. S., Banks, S. and Harle, M. (2004b), 
‘Outcomes from a therapeutic community for homeless addicted mothers and their 
children’, Administration and Policy in Mental Health 31, pp. 313–338. 
USA Secondary analyses of 
previously published data (De 
Leon et al., 2000)
 4.  Condelli, W. S., Koch, M. A. and Fletcher, B. (2000), ‘Treatment refusal/attrition 
among adults randomly assigned to programs at a drug treatment campus. The New 
Jersey substance abuse treatment campus, Seacaucus, NJ’, Journal of Substance 
Abuse Treatment 18, pp. 395–407.
USA Only during-treatment 
outcomes reported
 5.  McGeary, K. A., French, M. T., Sacks, S., McKendrick, K. and De Leon, G. (2000), 
‘Service use and cost by mentally ill chemical abusers: differences by retention in a 
therapeutic community’, Journal of Substance Abuse 11, pp. 265–279.
USA Analysis of outcome 
correlates
 6.  Messina, N., Wish, E. and Nemes, S. (2000), ‘Predictors of treatment outcomes in 
men and women admitted to a therapeutic community’, American Journal of Drug 
and Alcohol Abuse 26, pp. 207–227.
USA Secondary analyses of 
previously published data 
(Nemes et al., 1999)
 7.  Messina, N. P., Wish, E. D. and Nemes, S. (1999), ‘Therapeutic community treatment 
for substance abusers with antisocial personality disorder’, Journal of Substance 
Abuse Treatment 17, pp. 121–128.
USA Secondary analyses of 
previously published data 
(Nemes et al., 1999)
 8.  Moos, R. H., Moos, B. S. and Andrassy, J. M. (1999), ‘Outcomes of four treatment 
approaches in community residential programs for patients with substance use 
disorders’, Psychiatric Services 50, pp. 1577–1583. 
USA Not a controlled study design
 9.  Toumbourou, J. W., Hamilton, M. and Fallon, B. (1998), ‘Treatment level progress and 
time spent in treatment in the prediction of outcomes following drug-free 
therapeutic community treatment’, Addiction 93, pp. 1051–1064. 
USA Not a controlled study design
10.  Liberty, H. J., Johnson, B. D., Jainchill, N., Ryder, J., Messina, M., Reinolds, S. and 
Hossain, M. (1998), ‘Dynamic recovery: comparative study of therapeutic 
communities in homeless shelters for men’, Journal of Substance Abuse Treatment 
15, pp. 401–423.
USA Not a controlled study design
11.  Graham, W. F. and Wexler, H. K. (1997), ‘The Amity therapeutic community program 
at Donovan prison: program description and approach’, in: De Leon, G. (ed.), 
Community as method. Therapeutic communities for special populations and 
special settings, Praeger, Westport, CT, pp. 69–86. 
USA Not a controlled study design
12.  Knight, K., Simpson, D. D., Chatham, L. R. and Camacho, L. M. (1997), ‘An 
assessment of prison-based drug treatment: Texas’ in-prison therapeutic 
community program’, Journal of Offender Rehabilitation 24, pp. 75–100. 
USA Not a controlled study design
13.  McCusker, J., Bigelow, C., Vickers-Lahti, M., Spotts, D., Garfield, F. and Frost, R. 
(1997b), ‘Planned duration of residential drug abuse treatment: efficacy versus 
effectiveness’, Addiction 92, pp. 1467–1478. 
USA Secondary analyses of 
previously published data 
(McCusker et al., 1995)
14.  Martin, S. S., Butzin, C. A. and Inciardi, J. (1995), ‘Assessment of a multistage 
therapeutic community for drug-involved offenders’, Journal of Psychoactive Drugs 
27, pp. 109–116.
USA Secondary analyses of 
previously published data 
(Lockwood et al., 1997)
15.  Rice, M. E., Harris, G. T. and Cormier, C. A. (1992), ‘An evaluation of a maximum 
security therapeutic community for psychopaths and other mentally disordered 
offenders’, Law and Human Behaviour 16, pp. 399–412. 
USA Not a controlled study design
16.  Charuvastra, V. C., Rehmar, R., Paredes, A. and McBride, M. (1989), ‘Drug-free 
therapeutic community — a 10 year follow-up’, Addictive Behaviors 14,  
pp. 343–345. 
USA Not a controlled study design
17.  Barr, H. (1986), ‘Outcomes in drug abuse treatment in two modalities’, in: De Leon, 
G. and Zeigenfuss, J. T. (eds.), Therapeutic communities for addictions, Charles C. 
Thomas Publications, Springfield, IL, pp. 97–108.
USA Not a controlled study design
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I  Annex D 
Overview of prison therapeutic community papers reporting controlled research
Reference
Comparison 
condition
Time to 
follow-up 
(months)
Outcome measures
Substance  
use reduc-  
tion or  
abstinence
Relapse 
or time to 
relapse
Reduction 
in criminal 
activity or 
reoffending
Re-arrest  
or reincar- 
ceration
Employment Health
Sacks et al. (2012) TAU 12 +
Zhang et al. (2011) No treatment 
(standard work 
release)
12 =
60 =
Messina et al. (2010) Other TC 6 = =
12 = =
Welsh (2007) TAU 24 = + +
Sullivan et al. (2007) TAU 12 + Illicit drugs
+ Alcohol
+
Sacks et al. (2004) TAU 12 +
Morral et al. (2004) No treatment 
(standard work 
release)
12 + = +
Inciardi et al. (2004) No treatment 
(standard work 
release)
42 + +
60 + +
Martin et al. (1999) Other TC 18 + +
Lockwood et al. (1997) Other TC 6 + +
Nielsen et al. (1996) No treatment 
(standard work 
release)
6 + +
18 + +
Guydish et al.  
(1998, 1999)
Other TC 12 +
18 +
6 +
Prendergast et al.  
(2003, 2004)
No treatment  
(on waiting list)
12 + +
60 = + = =
Wexler et al. (1999) No treatment  
(on waiting list)
12 +
24 +
Hartman et al. (1997) No treatment 
(standard work 
release)
5 + +
Note:
+ statistically significant difference in favour of study treatment
= no difference in outcome between treatment conditions.
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Overview of community therapeutic community papers reporting controlled research
Reference 
Comparison 
condition
Time to 
follow-up 
(months)
Outcome measures
Substance 
use reduc-  
tion or 
abstinence
Relapse 
or time to 
relapse
Reduction 
in criminal 
activity or 
reoffending
Re-arrest  
or reincar- 
ceration
Employment Health 
Greenwood et al. 
(2001)
Other TC 6 +
12 =
18 =
De Leon et al. (2000) TAU 12 + Illicit drugs
+ Alcohol
= + =
24 + Illicit drugs
+ Alcohol
+ + +
Nemes et al. (1999) Other TC 18 + + +
French et al. (1999) TAU 24 = + = +
Nuttbrock et al. (1998) No treatment 
(community 
residency)
12 + =
McCusker et al. (1997a, 
1995, 1996)
Other TC 3 = = +
3–6 =
6 + 
Bale et al. (1984) TAU (five-day 
detoxification)
24 + Heroin
+ Other illicit 
drugs
– Alcohol
+ +
Coombs (1981) Other TC 12 + +
Bale et al. (1980) TAU (MMT; 
detoxification)
12 + + +
Guydish et al.  
(1998, 1999)
Other TC 12 +
18 +
6 +
Note
+ statistically significant difference in favour of study treatment
– statistically significant difference in favour of comparison condition
= no difference in outcome between treatment conditions.
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I  Annex F 
Observational studies excluded from this review
Full study reference Country Reason for exclusion
1.  Soyez, V., De Leon, G., Broekaert, E. and Rosseel, Y. (2006), ‘The impact of a social 
network intervention on retention in Belgian therapeutic communities: a quasi-
experimental study’, Addiction 101, pp. 1027–1034. 
Belgium Analysis of outcome 
correlates
2.  Ravndal, E. and Vaglum, P. (1994), ‘Treatment of female addicts: the importance of 
relationships to parents, partners and peer for the outcome’, International Journal of 
the Addictions 29, pp. 115–125. 
Norway Secondary analyses of 
previously published data
3.  Ravndal, E. and Vaglum, P. (1994), ‘Self-reported depression as a predictor of dropout 
in a hierarchical therapeutic community’, Journal of Substance Abuse Treatment 11, 
pp. 471–479. 
Norway Only during-treatment 
outcomes reported
4.  Ravndal, E. and Vaglum, P. (1994), ‘Why do drug abusers leave the therapeutic 
community? Problems with attachment and identification in a hierarchical 
therapeutic community’, Nordic Journal of Psychiatry 33, pp. 4–55. 
Norway Only during-treatment 
outcomes reported
5.  Ravndal, E. and Vaglum, P. (1992), ‘Different intake procedures: the influence on 
treatment start and treatment response. A quasi-experimental study’, Journal of 
Substance Abuse Treatment 9, pp. 53–58. 
Norway Only during-treatment 
outcomes reported
6.  Ravndal, E. and Vaglum, P. (1991), ‘Psychopathology and substance abuse as 
predictors of program completion in a therapeutic community for drug abusers: a 
prospective study’, Acta Psychiatrica Scandinavica 83, pp. 217–222. 
Norway Only during-treatment 
outcomes reported
7.  Ravndal, E. and Vaglum, P. (1991), ‘Changes in antisocial aggressiveness during 
treatment in a hierarchical therapeutic community. A prospective study of personality 
changes’, Acta Psychiatrica Scandinavica 84, pp. 524–530.
Norway Only during-treatment 
outcomes reported
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